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CHAPTER 1: GENERAL INTRODUCTION 
 
Research Motivation and Goals 
Communication pathways in cells are of fundamental importance to overall health. 
Components of the cell membrane play a critical role in these pathways and are often the 
target of various drug treatments. Cell membrane organization can provide insight into how 
cells respond to their environment and ultimately provide the knowledge needed to 
understand disease regulation. Membrane receptors are important intermediaries in the 
transmission of information across the cell membrane. Integrins are one of the main 
transmembrane proteins on animal cells that bind to extracellular matrix. These proteins 
integrate the extracellular matrix with the intracellular cytoskeleton. Individually, integrins 
bind to ligand with low affinity (µM-1 to mM-1), but their ability to cluster within the cell 
membrane facilitates strong adherence to the extracellular matrix [1]. They are known to be 
involved in cell signaling, growth and differentiation [2]. Deviations in integrin signaling can 
cause disease ranging from metastasis to angiogenesis [3]. 
It is the goal of this work to measure integrin clustering and diffusion properties in 
the presence of altered extracellular, membrane, and cellular compositions in order to 
elucidate the molecular mechanisms of integrins. Changes in integrin diffusion and clustering 
are measured using select fluorescence microscopy techniques. FRET, fluorescence 
resonance energy transfer, is a technique that measures interactions on the 0 to 10 nanometer 
scale. While FRAP, fluorescence recovery after photobleaching, monitors the two-
dimensional diffusion of fluorescent molecules into a previously photobleached area. 
 
 
 Cell Membrane  
As the structural and functional unit of living organisms, cells perform
of functions, including energy conversion, 
includes many organelles that
membrane. The dynamic nature of the cell is evidenced by 
and become specialized; as wel
its environment. 
 The membrane is a lipid bilyer with e
small biomolecules (Figure 1
what passes into/out of the cell. Based on the fluid mosaic model 
as a two-dimensional liquid. However, biological details are more involved than 
and the large number of proteins present 
inhibit Brownian diffusion [5]
networks of proteins are what sustain basic cellular function 
protein structures and interactions 
morphology [7,8]. 
Figure 1: Schematic representation of a cell
lipids, carbohydrates, and other small biomolecules.  Integrins are a class of proteins that 
span the membrane and are involved in cell signaling  
 
molecule transport, and reproduction.
 are separated from the surrounding environment by the 
its capacity to grow, reproduce, 
l as by its ability to respond to stimuli and adapt
mbedded proteins, carbohydrates and other 
). It is a semipermeable membrane and therefore able to regulate 
[4], the membrane is seen 
in the cell membrane provides structure and can 
. In fact, the interconnectivity and spatial organization of 
[6]. New data on membrane 
have transformed our understanding of membrane
 
: The cell membrane is composed of protei
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 a wide variety 
 The cell 
cell 
 to changes in 
this model 
 
ns, 
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Integrins 
One process for transmitting information across the cell membrane is achieved via 
integrins, which are membrane proteins that are critical to many cellular processes including 
cell adhesion, growth, and differentiation [2]. Integrins are composed of an α and β subunit 
that are non-covalently associated and usually consist of a short cytoplasmic tail with a large 
extracellular ligand binding domain (Figure 2). The short cytoplasmic tail interacts with the 
actin cytoskeleton indirectly though a number of adapter proteins, such as vinculin, steamer 
duck, and paxillin. Integrin conformations exist in equilibrium within the cell, however, 
when this equilibrium shifts toward a greater number of the integrins’ extracellular region 
being extended, there is an increase in ligand affinity [9]. Many probes are available to 
measure structural changes in receptors [10-12].  More recently studies have looked at the 
clustering properties of integrins [13,14].   
 
Figure 2: Integrins span the cell membrane and consist of a large extracellular domain, a 
transmembrane region, and a short cytoplasmic domain.  Integrins in the bent conformation 
are considered to have a low extracellular ligand affinity. (Adapted from reference 15)  
 
 
 
 Fluorescence Microscopy 
Fluorescence is the absorption of photons at a particular wavelength to promote 
electronic excitation and the subsequent emission of light with a lower energy 
to the loss of energy through heat or mol
(less than 10-9sec) due to the short time delay between photon absorption and emission. 
Fluorophores are identified on the basis of their excitation and emission properties. 
Due to high sensitivity and
cell biology.  The high sensitivity and specificity are the result of the discovery and cloning 
of the green fluorescent protein (GFP), which made it possible to express GFP fused to a 
particular protein of interest throughout a given cell or organism. This break
in the awarding of the Noble Prize in Chemistry to Osamu Shimomura, Martin Chalfie, and 
Roger Y. Tsien in 2008. 
 
Figure 3: Jablonski Diagram: A fluorophore absorbs energy, 
energy through nonradiative decay and emits at a longer wavelength  
 
 
 
ecular vibration. This process is nearly simultaneous 
 specificity, florescence microscopy is commonly used in 
-
loses a small amount of the 
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Fluorescence Recovery after Photobleaching (FRAP) 
FRAP quantifies the diffusion of fluorophores in the cell membrane by 
photobleaching a small region and monitoring the recovery of surrounding molecules back 
into the photobleached area. Assuming the bleaching beam has a Gaussian profile, Brownian 
diffusion (D) is modeled by the following equation (Eq. 1): 
   

/
   (Eq. 1) 
where ω = radius of the photobleaching beam, and t1/2= the time required for the bleach spot 
to recover to half its initial intensity [15]. 
The Saffman-Delbrück equation (Eq. 2) predicts diffusion in a two-dimensional 
membrane to be on the order of magnitude of 10-8 cm2/s:  


   


 0.5572  (Eq. 2) 
where Dcalc = lateral diffusion, k = Boltzmann constant, T = temperature, a = radius of the 
diffusing object, h = membrane thickness, ηm = viscosity of membrane, and ηw = viscosity of 
surrounding aqueous medium. This value, however, is faster than the experimentally 
measured values of proteins in the membrane [16]. Multiple reasons exist for this slower than 
expected diffusion of membrane proteins: interactions with extracellular and cytoplasmic 
proteins, higher concentrations of membrane proteins, and/or the confinement of proteins to 
different sized domains within the membrane. These associations are studied in the following 
chapters. 
 
 
 
 Förester Resonance Energy Transfer (FRET
FRET is the radiationless transfer of energy between two fluorophores. If appropriate 
spectral overlap exists between 
close proximity (0-10 nm) to one another
the donor molecule transfers its energy via a dipole
4). The acceptor then emits the photon at a longer wavelength than that of the donor. The 
Förester distance (R0) (Figure 
efficiency of energy transfer is 50%. This distance is dependent on 
overlap of the donor emission spectrum with that of the acceptor absorption spectrum, the 
fluorophore molecular orientation, the don
the surrounding medium. 
 
Figure 4: Jablonski diagram: Depiction of (FRET) (adapted from Nikon Inc.)
) 
the FRET donor and acceptor and the two molecules are in 
, instead of emitting a photon after ligh
-dipole interaction to the acceptor (
5) is the distance between the donor and acceptor where the 
several factors: 
or quantum yield, and the index of refraction of 
6 
t absorption, 
Figure 
the 
 
 
 Figure 5: The Förester distance (R
donor and acceptor where the efficiency of energy transfer is 50%.  
 
Text from this review will be incorporated into a review article on single cell analysis with 
Donor-Acceptor Fluorescence Resonance Energy Transfer (FRE
The sensitivity of fluorescence makes it a widely used technique for a broad range of 
applications. Among other purposes, fluorescence microscopy can be used to measure 
trajectory, speed and timing of molecular and cellular movements. One fluorescence 
technique, fluorescence resonance energy transfer (FRET), has become extensively used to 
measure biological interactions on the nanometer scale. Live cell FRET measurements use 
carefully chosen fluorescence proteins fused to the protein(s) of interest or small
that bind to specific targets.  
There are several factors that need to be addressed when choosing a donor and 
acceptor including: (a) sufficient separation of donor and acceptor absorption spectra to 
obtain selective excitation of the fluoropho
donor and the excitation spectrum of the acceptor, (c) reasonable separation in emission 
spectra to allow independent measurement of the fluorescence of each fluorophore, (d) 
 
0) in FRET measurements is the distance between the 
 
Literature Review: 
 
multiple contributing authors 
 
T) Pairs
 
 
res, (b) overlap of the emission spectrum of the 
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extinction coefficients and (e) quantum yields of the fluorophores. The importance of several 
of the spectral factors discussed above (a, b, c) are shown in Figure 6, which depicts one of 
the most commonly used FRET pairs: cyan fluorescent protein as the donor and yellow 
fluorescent protein as the acceptor (CFP-YFP).   
 
 
Figure 6: Excitation and emission spectra of a typical FRET pair Dabs = donor absorbance, 
Dem = donor emission, Aabs = acceptor absorbance, Aabs = acceptor emission. (adapted from 
reference 17).  
 
Generally there are two main types of fluorophores used for live cell FRET: (i) 
autofluorescent proteins that are expressed using the cell's transcription and translation 
machinery and (ii) small organic fluorophores that are chemically synthesized. In addition to 
GFP, there are other fluorescent proteins, such as dsRED. These naturally occurring 
fluorescent proteins have been modified to produce an entire color palette of fluorescent 
proteins with suitable properties for FRET. Some popular fluorescent protein FRET pairs that 
have been used over the years include cyan fluorescent protein-yellow fluorescent protein 
(CFP-YFP), CFP-dsRED, and YFP-dsRED. There has also been development in small 
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molecule fluorophores which provides more options than just the available genetically 
encoded fluorophores. Additionally, their size is drastically smaller than that of fluorescent 
proteins (27 kDa) [17]. This literature review will cover the donor and acceptor probes from 
both groups that have been developed within the last five years for FRET measurements 
using one or two FRET pairs within a given system. This review will also discuss the use of 
quenchers, optical switches, and computational tools to expand the capabilities of FRET 
measurements. 
 
Fluorescent Proteins 
Currently known fluorescent protein pairs have different limitations and new pairs are 
constantly being sought that will provide an optimal combination of donor and acceptor to 
enable large dynamic range FRET measurements, fast maturation (i.e. protein folding), bright 
fluorescence, and reliable detection. Much research has been done to address these concerns 
and improve systems of measurement. Novel FRET pairs that have been identified include 
mutant green fluorescent protein (TagGFP)-mutant red fluorescent protein (TagRFP) and 
GFP2 and DsRed2. While these FRET pairs have been tested in a particular biological 
context, they should be applicable to a whole range of systems. 
Screens for high efficiency FRET pairs compared the amplitude of fluorescence 
before and after protein separation and identified TagGFP–TagRFP as a promising FRET 
pair. Further characterization showed the Förester radius for this FRET pair to be higher than 
GFP-mCherry, with high pH stability and an emission signal that can be separated in most 
imaging systems. This novel FRET pair was used in combination with caspase 3 to generate 
an effective apoptosis reporter [18]. 
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Another advantageous FRET pair that was identified as potentially beneficial 
compared to the CFP-YFP is GFP2 and DsRed2. Specifically, the quality of the probes was 
monitored by co-transfecting the fluorescent proteins into cells and monitoring their energy 
transfer. As a proof of concept, these fluorophores were connected via a peptide containing a 
cleavage motif for the enterovirus 2A protease. Energy transfer is measured until cleavage of 
the enterovirus occurs. Resulting FRET decay is monitored as a function of quantity and 
duration of the virus. This FRET system can be used in diagnostics and screening procedures 
[19]. 
In addition to creating new FRET pairs, another approach is to make modifications on 
a previously existing FRET pair, such as CFP-YFP.  One group replaced YFP with a variant 
sREACh (super resonance energy accepting chromoprotein) which has low quantum 
efficiency and high absorbance [20]. Another group used sREACh and tested 3 possible 
replacements for CFP and found that using a two photon excitation microscope mTFP1 
(monomeric teal fluorescent protein) had the highest gain on epidermal growth factor 
stimulation [21]. Using modified YFP-CFP maximizes parameters that are important to 
FRET pairs as discussed above. 
Changes to where fluorophores are attached to proteins can also be made and was 
shown to improve spatiotemporal resolution. To study protein-protein interactions florescent 
proteins are often fused to one of the termini of the host protein. Efforts have to be made, 
however, to minimize disruption of protein folding as well as maximize FRET. One group 
engineered periplasmic binding proteins with increased separation between the YFP and CFP 
which were attached to both termini of periplasmic binding proteins. The resulting constructs 
showed a larger FRET dynamic range than their native forms [22].  
11 
 
Small Molecules 
Specific labeling techniques for biomolecules, not directly encoded by the genome, 
have been limited.  This is in part due to difficulties in selectively labeling the molecule of 
interest without affecting its molecular recognition in the cell, thus limiting the number of 
molecules available for cell-based studies. Accurate measurement of small molecules in cells 
using FRET contributes towards understanding different interactions of individual molecules 
in signaling networks, tracking metal ions in cells, and analyzing other important cell 
functions that can be studied without genetic manipulation, such as metabolic regulation [23]. 
Monitoring azides in cells was achieved by creating a fluorogenic phosphine reagent 
containing a FRET quencher that is activated upon reaction with azides [24]. 
A class of caged coumarin probes was developed that has a high FRET efficiency and 
promising chemistry for bioconjugation. Calcein was chosen as the acceptor due to its water 
solubility, long cytoplasmic retention time and the extensive spectral overlap of the 
excitation wavelength with coumarin’s emission. Chemistries of iminodiacetates and dextrin 
amines were utilized to conjugate the caged FRET dye. This dye can be localized by exciting 
it near 490 nm prior to photolysis [25]. 
 The development of a borondipyrromethanene (BODIPY)-rhodamine complex has 
good spectral overlap due to the presence of a biphenyl spacer that allowed for efficient 
energy transfer. Mercury acceptors were introduced into the complex and showed excellent 
sensitivity and selectivity as well as insensitivity to pH [26]. The 2’-carboxyl group of the 
rhodamine can be used to develop a molecular ruler for a wide range of transition-metal ions.   
A probe that can be used to measure mechanical force in proteins via FRET was 
created. CFP and YFP were attached to two distant sites of single-stranded DNA of the 
12 
 
spectrin protein. Single-stranded DNA is floppy and causes minimal stress in the protein.  
However, once it binds to complementary DNA sequence the loop straightens, pushing the 
fluorophores apart and decreasing FRET over time.  This probe is reliable, has high 
sensitivity, and doesn’t create interference with protein function [27]. 
Dual FRET 
Over the years there have been many genetically encoded sensors developed based on 
the concept of FRET as discussed above, which provide a means of monitoring a variety of 
interactions within the cell. The ability to simultaneously measure multiple interactions 
within the cell would help in the development of an understanding of different complex 
signaling networks. However, due to broad spectral signals, often significant fluorophore 
overlap is observed. Efforts to resolve this difficulty have included temporally separating the 
FRET signal using spectrally compatible sets of FRET pairs. In this strategy, the second 
donor is excited immediately after excitation of the first donor and the subsequent emission 
from the acceptors are collected. These sets include ECFP/Venus and TagRFP/mPlum [28], 
ECFP/YFP and pmOrange/mCherry [29], and mTFP1/mCitrine and mAmetrine/tdTomate 
[30]. One difficulty with sequential data collection, however, is the time lapse between the 
collected data, making it impractical for interactions that are occurring on a faster time scale. 
To address the poor time resolution in dual FRET measurements, a single-excitation 
dual-FRET method was developed. A single excitation wavelength is used with subsequent 
linear unmixing to identify between fluorescent proteins. One group used sapphire/red 
fluorescent protein FRET sensor in combination with CFP/YFP. Both sapphire and CFP were 
excited simultaneously at 405 nm (Figure 7) and resulting signal was comparable to single 
FRET measurements. This method can be used in a variety of cell samples [31]. Kim et al. 
13 
 
used CFP/YFP and YFP/mCherry pairs obtaining selective excitation of the donor. To unmix 
the spectral imaging data of the acceptors, a non-negative matrix factorization was applied.  
This technique eliminated donor bleedthrough and autofluorescence and minimizes 
calculation artifacts [32].  
 A red shifted FRET pair, mVenus/mKOκ biosensor, was developed and used in 
combination with human glutaredoxin-1 and a fluorescent protein Grx1-roGFP2. These 
spectrally compatible probes had minimal cross-talk and were shown to exhibit great 
spatiotemporal precision. As proof of concept, simultaneous imaging of Src/Ca2+ signaling 
and glutathione redox potential were measured, revealing that the epidermal growth factor-
induced Src signaling is negatively regulated by H2O2 [33]. 
 
Figure 7: Emission spectra of fluorescent proteins and transmittances of dichroic mirrors and 
emission filters. Broken lines from left to right indicate the transmission curves of LP455, 
500, 530, and 570, and cyan, green, yellow, and red shaded areas represent of 
BP487/25, 515/30, 550/40, and 590/40 in (LP = long pass, BP = Band pass numbers indicate 
wavelength and wavelength/half-bandwidth (nm) respectively). (adapted from reference 32)  
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Fluorescence Quenchers 
A non-fluorescent dye, IRDye QC-1, was developed to efficiently quench 
fluorophores ranging from visible to near-infrared wavelengths in FRET systems. Dye 
performance was tested by measuring efficiencies in a caspase-3 assay system with various 
donors all of which showed a 40 to 83-fold increase in fluorescence upon cleavage of the 
substrates. This effective quenching on a broad range of dyes gives broad applicability in 
FRET assays [34]. 
Studies have shown that fluorescence quenching of the acceptor occurs on a bridged 
organic dyad where triphenyldiamine is the donor and perylenebisimide is the acceptor. This 
quenching is absent in a solution of free donors and acceptors indicating that it may be due to 
the presence of the saturated CH2O(CH2)12 –bridge. This idea was investigated using time-
dependent density functional theory (DFT) and molecular dynamics (MD). Calculations 
comparing a mixture of free donors and acceptors were compared to a bridged molecule in 
stretched conformation. DFT revealed that the bridge's influence over the donor and acceptor 
electronic spectra was negligible. However, MD showed that the quenching is caused when 
the bridge in solution thereby minimizing donor acceptor distances, causing an overlap of 
spectra [35]. 
In an effort to improve and develop FRET biosensors, conformational changes in 
protein folding are modeled using a Fusion Protein Modeler (FPMOD), a computational tool 
that qualitatively predicts changes in FRET efficiency by sampling the conformational space 
through rigid-body rotation. Although the correlation between changes in FRET efficiency 
and emission ratio is difficult to quantify, the values should be directly related. This model 
was used to evaluate Ca2+ biosensor designs and create a new Ca2+ biosensor. Models were 
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shown to have good agreement with experimental results. Incorporation of additional effects 
has the potential to remove non-optimal conformations and create better quantitative 
correlation between simulation and experiment [36]. 
Development of polypeptides to measure changes in oxidation states was achieved by 
inserting redox sensitive motifs between ECFP and EYFP. The resulting construct showed a 
92% increase in FRET efficiency upon oxidation. These constructs can be used to measure 
intracellular or intraorganellar redox conditions [37]. 
 
Optical Switches 
Optical switches generate a powerful and precise means to employ phase-selective 
detection of donor signals associated with the presence or absence of FRET.  
Nitrobenzospiropyran (NitroBIPS) attached to a GFP-alkylguaninetransferase fusion protein 
(GFP-AGT) is one such combination used as an optical switch that showed an increase in the 
sensitivity of detection [38]. Another example uses the small molecule tetramethylrhodamine 
(TMR) in combination with spironaphthoxazine (NISO), an optical switch that has enhanced 
quantum yields.  NISO transitions between a colorless and colorful state and serves as the 
acceptor probe in FRET while TMR is the donor. The optical switching of the probe is 
reversible without additional reactants, making this probe conducive to measurements in cells 
[39]. Related probes have been identified, but face limitations due to overlapping emission 
spectra of the fluorescent probe and optical switch. This limitation is overcome due to the 
fact that the absorption spectrum of NISO is red shifted, maximizing FRET efficiency.   
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Dissertation Overview 
 
 This dissertation utilizes fluorescence microscopy to better understand the dynamics 
and organization of the cell membrane and how cytoplasmic proteins, extracellular ligand, 
and cholesterol affect this organization. Chapter 1 provides a general introduction to 
fluorescence microscopy and integrins, a transmembrane protein necessary for many cellular 
processes including adhesion, growth, and differentiation. It also includes a literature review 
on FRET donor acceptor pairs that have been developed in the last 5 years. Chapter 2 is a 
paper published in a special issue of Analytical and Bioanalytical Chemistry in 2012: Young 
Investigators in Analytical and Bioanalytical Science, which discusses how the reduced 
expression of different cytoplasmic proteins affects integrin diffusion. Chapter 3 focuses on 
the nanoscale clustering of integrins and mutant integrins in the presence of ligand. Chapter 
4 compares integrin diffusion in the presence of cholesterol and epicholesterol. Chapter 5 
contains general conclusions and possible directions for future wok.  
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CHAPTER 2: ELUCIDATING THE ROLE OF SELECT 
CYTOPLASMIC PROTEINS IN ALTERING DIFFUSION OF 
INTEGRIN RECEPTORS  
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ABSTRACT 
 Cytoplasmic proteins that affect integrin diffusion in the cell membrane are identified 
using a combination of fluorescence recovery after photobleaching (FRAP) and RNA 
interference. Integrin receptors are essential for many cellular events, and alterations in 
lateral diffusion are one mechanism for modulating their function. In cells expressing native 
cytoplasmic protein concentrations and spread on a slide containing integrin extracellular 
ligand, 45 ± 2% of the integrin is mobile with a time-dependent 5.2 ± 0.9 x 10-9 cm2/sec 
diffusion coefficient at 1 second. The time exponent is 0.90 ± 0.07, indicating integrin 
diffusion moderately slows at longer times. The role of a specific cytoplasmic protein in 
altering integrin diffusion is revealed through changes in the FRAP curve after reducing the 
cytoplasmic protein’s 
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Copyright © Springer 2012 
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expression. Decreased expression of cytoplasmic proteins rhea, focal adhesion kinase (FAK) 
or steamer duck decreases the integrin mobile fraction. For rhea and FAK there is a  
concomitant shift to Brownian (i.e., time-independent) diffusion at reduced concentrations of  
these proteins. In contrast, when the expression of actin 42A, dreadlocks, paxillin, integrin 
linked kinase (ILK), or vinculin is reduced, integrin diffusion generally becomes more 
constrained with an increase in the integrin mobile fraction. This same change in integrin 
diffusion is measured in the absence of integrin extracellular ligand. The results indicate 
breaking the extracellular ligand-integrin-cytoskeletal linkage alters integrin diffusion 
properties, and, in most cases there is no correlation between integrin and lipid diffusion 
properties.  
 
INTRODUCTION 
Alterations in the lateral diffusion of lipids, proteins, and small molecules in the cell 
membrane occur in response to a variety of stimuli, ranging from protein binding [1] to 
mechanical forces emanating from inside or outside the cell [2,3]. The unrestricted lateral 
diffusion coefficient of membrane components can be roughly estimated by the Saffman-
Delbrück equation [4]. Calculated values are on the order of 10-8 cm2/sec for a typical 
membrane protein, and lipids have similar diffusion coefficients that are larger only by a 
factor of ~2 [5,6]. The lateral diffusion of membrane proteins is usually slower than values 
measured for proteins in model lipid bilayers and values calculated using the Saffman-
Delbrück equation [7,8]. This is due to three primary factors: (1) membrane proteins interact 
with extracellular and cytoskeletal/cytoplasmic proteins; (2) the cell membrane contains a 
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high concentration of proteins, e.g. 50-80% of the membrane surface area; and (3) membrane 
components may be confined to domains of varying size, all of which constrain lateral 
diffusion. In erythrocyte cells lacking key cytoskeletal proteins, the lateral diffusion of a 
membrane protein increased over 50-fold compared with cells containing all cytoskeletal 
proteins, indicating that cytoplasmic proteins play a role in altering the lateral diffusion of at 
least some membrane components [9]. Altered lateral diffusion of mutant membrane proteins 
with cytoplasmic domains that have been eliminated or shortened can reveal the role of 
cytoplasmic domains in altering lateral diffusion, but they do not provide information about 
specific cytoplasmic proteins that may be responsible for altered lateral diffusion.  
Several analytical techniques can be used to measure lateral diffusion of membrane 
components. Single particle tracking [10] and fluorescence correlation spectroscopy [11] can 
be used to reveal heterogeneous diffusion of membrane components. These techniques 
require approximately nanomolar concentrations of analyte (e.g., fluorophore labeled 
protein), which is often significantly below relevant in vivo concentrations [12]. Fluorescence 
recovery after photobleaching (FRAP) can be used to monitor the time required for 
fluorescent molecules to laterally diffuse into a region of the cell that has previously been 
photobleached.  The photobleached region can be generated by a short, intense laser pulse. 
FRAP is an ensemble measurement that averages the movement of numerous proteins, which 
may represent populations with different diffusion characteristics. Possible rare populations 
may be masked in the ensemble measurement. Fluorescent fusion proteins enable in vivo and 
ex vivo FRAP measurements of a membrane protein at endogenous expression levels [13]. 
Several models have been developed to extract diffusion parameters of membrane 
components from fluorescence recovery curves [14-16]. Combined with techniques to alter 
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the expression of other proteins, FRAP has the capability for measuring the molecular 
mechanism of receptor diffusion in the cell membrane.  
Integrins are a family of heterodimeric receptors that contain an α and a β subunit 
with large extracellular domains and comparatively short cytoplasmic domains [2]. Several 
cytoplasmic proteins interact directly or indirectly with integrins; however, the effects of 
such interactions in altering their lateral movement in the cell membrane are not well 
understood. A method utilizing FRAP has been described to elucidate the dynamics of focal 
adhesions, which are integrin containing macromolecular assemblies that link cells to the 
extracellular matrix [17]. In this previously published method, the lateral mobility was 
measured for integrin mutants that disrupt known binding sites to other focal adhesion 
proteins, and was limited to study proteins that directly bind at known locations on the 
integrin. The cloning step required to generate integrin mutants also makes the methodology 
low-throughput. FRAP has also been used to measure changes in integrin diffusion when 
bound to multimeric ligands compared with monovalent ligands [18]. It was shown that 
integrin lateral diffusion decreases when bound to a tetrameric ligand compared to a 
monovalent ligand.  
In this current study, RNA interference (RNAi) was used to decrease the expression 
of select cytoplasmic proteins and the resulting changes in lipid and integrin diffusion were 
subsequently measured by FRAP in Drosophila melanogaster S2 cells (Fig. 1) [19-22]. 
Whole-genome RNAi studies have primarily measured an easily observed cellular 
phenotype.  When a more complex property such as membrane diffusion is measured, whole-
genome studies become less economically and experimentally feasible. However, measuring 
a chosen subset of target proteins can be insightful. The cytoplasmic proteins included in this 
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study for RNAi targeting include focal adhesion kinase (FAK), rhea, integrin linked kinase 
(ILK), paxillin, vinculin, dreadlocks, steamer duck, actin 42A, and akt1. These proteins have 
a role in integrin signaling, associate with integrins or the cytoskeleton. Focal adhesions 
incorporate vinculin, paxillin, rhea, and FAK. Akt1 is a kinase that is not located within focal 
adhesions, but it is known to interact with them via the PI-3 kinase [23]. Steamer duck and 
ILK are part of a protein complex that is assembled prior to integrin-dependent cell adhesion 
[24]. Dreadlocks is involved in cytoskeletal reorganization [25], and actin 42A is one of 6 
actins expressed in S2 cells.  All of the proteins selected in this study are highly conserved 
across diverse organisms, and information obtained from these experiments will expand the 
fundamental understanding of integrins function [26,27]. Rhea, dreadlocks, and steamer duck 
are homologs for the vertebrate proteins talin, Nck-2, and pinch, respectively. The 
fluorescence recovery curves were modeled to obtain diffusion coefficients, mobile fractions 
and modes of diffusion, which were compared before and after RNAi treatment.  In addition 
to FRAP measurements, real time polymerase chain reaction (RT PCR) was used to measure 
a reduction in mRNA concentration after RNAi treatment.   
 
METHODS 
Cell Preparation 
S2 cells were cultured in Shields and Sang M3 medium (M3, Sigma) with antibiotics 
and 10% fetal calf serum (FCS) as previously published [28]. Permanently transfected S2 
cells expressed wild-type αPS2CβPS integrins (αβ), or αPS2CβPS integrins with a Venus 
yellow fluorescent protein (αβ-Venus) inserted in the serine rich loop. The serine rich loop is 
an extracellular domain that has been previously used to insert epitope tags into this integrin 
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without disrupting the integrin function [29]. The αβ cell line was used to measure lipid 
diffusion and the αβ-Venus cell line was used to measure integrin diffusion. The αPS2CβPS 
integrin binds to the extracellular ligand tiggrin. These studies utilized a recombinant version 
of this protein, [30] whose concentration was determined via gel electrophoresis. Ligand 
coated microscope slides were prepared as previously described using 0.5 µg mL-1 tiggrin 
[31].   
Synthesis of double stranded RNA (dsRNA) and RNAi treatments have previously 
been described [32,33]. The cells were incubated with dsRNA for 4 days at 22˚C prior to 
analysis. The expression of all target proteins in S2 cells was confirmed using FLIGHT 
mRNA microarray expression database [34] and PeptideAtlas mass spectrometry proteomics 
database [35].  
Fluorescence Recovery After Photobleaching 
After incubation with dsRNA, the cells were transferred to a 14 mL centrifuge tube 
and heat shocked in a 36˚C water bath for 30 minutes to induce expression of integrins, 
which were under the control of the heat shock promoter. The cells were placed in a 22˚C 
incubator for 3 hours, and then centrifuged at 600xg for 3 minutes. The supernatant was 
removed and the cells were resuspended in M3 medium without FCS at a final concentration 
of 3x105 cells mL-1. For lipid diffusion measurements the M3 medium contained 
carbocyanine dye DiD (Invitrogen, 1,1'-dioctadecyl-3,3,3',3'- tetramethylindodicarbocyanine 
perchlorate) at a final concentration of 12 µM. For all measurements, 50 µl of cells were 
plated onto a tiggrin coated slide and allowed to spread for 1 h before rinsing the slide with 
BES Tyrodes buffer (200 mM BES, 1.37 M NaCl, 29 mM KCl, 1% w/v glucose, 1% w/v 
bovine serum albumin).  
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All fluorescence measurements were performed at room temperature utilizing an 
Eclipse TE2000U microscope (Nikon). A series of fluorescence images were collected before 
photobleaching the fluorophore and after photobleaching (recovery) using mercury lamp 
excitation. Example images are shown in Fig. 1. The exposure time for each image was 0.35 
seconds, and images were collected every 0.40 seconds. Photobleaching was accomplished 
with a laser, as outlined below. Lipid diffusion measurements used a x60 magnification, Plan 
Apo, 0.95 numerical aperture objective and a 635 nm diode laser (~300 µW at sample) was 
used to photobleach a 37 µm2 area of the plasma membrane labeled with DiD. Images were 
collected using a 645/20 nm excitation and a 660/20 nm emission filter.  Integrin diffusion 
measurements used a x100 magnification, Apo TIRF, 1.49 numerical aperture, oil immersion 
objective and the 488 nm line of an argon ion laser (~250 µW at sample) to photobleach a 41 
µm2 area of the cell membrane containing αβ-Venus. Venus images were collected using a 
500/20 nm excitation and a 535/30 nm emission filter. The Venus fluorescence intensity was 
lower than that for DiD; therefore, for Venus measurements the gain on the Princeton 
Instrument PhotonMax 512 CCD was set to its maximum value. Integrin diffusion 
coefficients were measured on ligand/BSA-coated or BSA-coated (10 mg mL-1) glass slides. 
No cell movement is measured in the time required to collect a complete FRAP data set. All 
fluorescence measurements included in this study were obtained on spread cells in the region 
between the perinuclear region and the cell edge (Fig. 1) to ensure that fluorescence 
contributions from intracellular YFP is minimal, as previously confirmed [31]. The focus was 
set to the apical surface, and the thickness of the cells ensures that the apical and basolateral 
surfaces are not probed simultaneously.  
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Data analysis 
Fluorescence images were analyzed using ImageJ version 1.38. Three intensities were 
measured for every image of the FRAP series: (1) the photobleached area of the plasma 
membrane corresponding to the area illuminated by the laser spot; (2) an area of the plasma 
membrane 10 µm away from the photobleached spot (No FRAP); and (3) a background area 
30 µm away from the cell (background).  All fluorescence intensities were background 
subtracted. FRAP curves are an average from seven to ten replicate measurements, and were 
normalized to the pre-photobleach fluorescence intensity. To account for photobleaching 
from the mercury lamp during the recovery phase, the average recovery curve was divided by 
the average No FRAP fluorescence intensity at each time point.  
The fluorescence recovery curves were fit to models based on Eq. 1[36] with an in-
house developed Igor Pro macro (version 4.0).  
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The parameter F0 is the initial fluorescence intensity after photobleaching; Fin is the 
fluorescence intensity at an infinite recovery time; τ
 
is the time for 50% of the fluorescence 
to recover; and α is the time exponent providing a measure of how much diffusion is 
constrained. Every FRAP curve was fit to three models. (1) The Brownian diffusion model 
sets α=1 and allows Fin < 1, corresponding to an immobile fraction. (2) The constrained, 
time-dependent diffusion model assumes no immobile fraction by setting Fin=1. (3) The third 
model incorporates time-dependent diffusion with an immobile fraction. Fits to the FRAP 
curve were weighted to the standard error of the pre-bleach fluorescence intensity. The 
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reduced chi2 was calculated as chi2 divided by the experimental degrees of freedom (Table 
1). The reduced chi2 values were compared to determine the most appropriate model for each 
data set, and a value of 1 indicates a good fit between the model and the experimental data. 
 The mobile fraction was calculated as: (Fin - Fo)/(1-Fo). The immobile fraction is 1 
minus the mobile fraction. The diffusion coefficient, D(t), was calculated by inserting τ and α 
obtained from the fit of the fluorescence recovery curve into Eq. 2.  
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where ω is the radius of the focused Gaussian laser beam and β is 1.075, 1.13, 1.15, 1.18, 
1.22, or 1.26 when the percent photobleach is 30, 45, 50, 55, 60, and 65, respectively. 
Diffusion parameters obtained for the best-fit model are listed in Tables 2 and 3 while those 
for the other models are shown in the Electronic supplemental material Tables S1 and S2. 
Error bars on all reported FRAP fit parameters represent uncertainties at the 95% confidence 
level. 
RT-PCR 
Isolation of mRNA from ~4x106 cells was achieved using Dynabeads mRNA Direct 
kit (Invitrogen 610.12) and quantified using the absorbance value at 260 nm. The reverse 
transcription of mRNA to cDNA (Applied Biosystems #4387406) was carried out at 37°C for 
60 minutes and the reaction terminated at 95°C for 5 minutes. The cDNA was combined with 
master mix (Applied Biosystems #4369016) and gene expression assay for the corresponding 
gene (Applied Biosystems: rhea Dm01841094_g1, FAK Dm01816810_m1, ILK 
Dm01843539_g1, actin 42A Dm02362162_s1, vinculin Dm01841855_g1, paxillin 
Dm02772085_s1, steamer duck Dm02135515_g1,  dreadlocks Dm01842270_g1, akt1 
28 
 
Dm02149560_g1, myospheroid Dm01843062_ g1, gamma tubulin at 23C Dm01841764). RT 
PCR used an initial temperature of 95°C for 10 minutes to activate the enzyme, followed by 
40 cycles (95°C for 15 s then 60°C for 60 s). Calibration curves were constructed using 
genomic DNA that was isolated from S2 cells with a Qiagen Kit (#69504). All steps were 
performed according to the manufacturers' provided protocols. Statistical significance of the 
results was determined using the software Rest 2009 [37].  
 
RESULTS AND DISCUSSION 
Integrin and lipid diffusion parameters at native cytoplasmic protein concentrations 
The main goal of this study was to elucidate the role of select cytoplasmic proteins in 
altering the lateral diffusion of αPS2CβPS integrins and lipids in the cell membrane of live 
S2 cells. Integrin diffusion coefficients were measured for cells spread on a mixed 
extracellular ligand/bovine serum albumin (BSA) coated microscope slide before RNAi 
treatment to obtain integrin diffusion parameters at native cytoplasmic protein 
concentrations. The extracellular ligand used in this study was a recombinant version of 
tiggrin, the native ligand for αPS2CβPS integrins. BSA fills in areas of the slide not occupied 
by ligand and prevents non-specific interactions between cell membrane components and the 
glass slide.  
The average integrin FRAP curve from replicate measurements (Fig 2A) was fit to 
models for (1) Brownian diffusion with an immobile fraction, (2) constrained, time-
dependent diffusion or (3) time-dependent diffusion with an immobile fraction. For cells 
spread on a ligand coated slide, the reduced chi2 value for each model was 1.3, 4.7, and 1.2, 
respectively (Table 1, control ligand). This indicates that integrin diffusion in the cell 
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membrane is best-modeled by time-dependent diffusion with a 55 ± 2% immobile fraction.  
The integrin diffusion coefficient is 5.2 ± 0.9 x 10-9 cm2/sec at 1 s, and slows to 3.6 ± 0.6 x 
10-9 cm2/sec at 50 s (Table 2, control ligand). Hereafter short analysis times refer to the 
diffusion coefficient at 1 s and long analysis times refer to the diffusion coefficient at 50 s. 
The time-dependent diffusion coefficient may be the result of periodic interactions with 
intracellular proteins, extracellular ligand, other membrane components; integrins undergoing 
conformational changes; or integrins partitioning between domains smaller than the probe 
area of the FRAP experiment and the bulk membrane. Similarly, there are many plausible 
explanations for the measured integrin immobile fraction. For example, the immobile 
integrin may be (1) bound to ligand immobilized on the microscope slide, (2) confined to 
nanoscale domains that do not exchange with the bulk membrane on the time scale of the 
FRAP experiment, (3) bound to a static cytoplasmic component or (4) a combination of 
aforementioned factors.  
To determine if the immobile fraction or the diffusion properties of the mobile 
integrin are ligand-dependent, FRAP curves were measured in cells spread on a BSA coated 
slide in the absence of ligand. The integrin immobile fraction is expected to decrease in the 
absence of ligand if this fraction represents ligand-bound protein. Comparing integrin FRAP 
curves in the presence or absence of ligand, the time-dependent diffusion with an immobile 
fraction model best-fits both curves (Table 1).  The immobile fraction decreases from 55 ± 
2% to 30 ± 3% in cells spread in the absence of integrin ligand (Table 2). The difference 
between these two numbers indicates that 25% of the immobile fraction is ligand-dependent, 
and this fraction likely represents integrin that is bound to immobile ligand.  For cells spread 
on a ligand containing slide, the remaining 30% ligand-independent immobile fraction may 
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be the result of hindered diffusion due to the presence of the microscope slide or any of the 
remaining explanations listed above. The percentage of the immobile fraction that is ligand-
dependent or ligand-independent may vary with the ligand concentration. The diffusion 
properties of the mobile integrin fraction are also altered in cells spread in the absence of 
ligand. Interestingly, the increase in the mobile fraction is accompanied by a 50% slower 
diffusion coefficient at long analysis times for cells spread in the absence of ligand (Table 2). 
This indicates that the extracellular matrix (ECM)-integrin linkage reduces diffusion 
constraints in the mobile fraction and at the same time reduces the fraction of integrins that 
are mobile.  
In contrast to the integrin diffusion properties, the lipid diffusion properties are 
independent of the presence or absence of extracellular ligand.  A combination of reduced 
chi2 values for the three diffusion models (Table 1) and time exponents equal to 
approximately 1 indicate that the lipid diffusion is Brownian (Table 3). The lipid mobile 
fraction is 35% higher than the integrin mobile fraction, and the lipid diffusion coefficient is 
approximately an order of magnitude faster (Table 3). The lipid diffusion coefficient is 30 ± 
3 (ligand) or 30 ± 2 (no ligand) x 10-9 cm2/sec (Table 3). The lipid diffusion parameters are 
consistent with several literature reports using different cell lines and experimental 
conditions [38,39]. The fastest diffusion coefficient that can be measured with the 
experimental parameters used in this study is 100 x 10-9 cm2/sec as revealed by modeled 
FRAP curves associated with varying diffusion coefficients (Fig. S1, green Electronic 
supplementary material).  
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Reduced mRNA Concentration for RNAi targeted proteins 
RNAi requires the lipid-assisted cellular uptake of approximately 500 base pair 
dsRNA (RNAi probe). Both the efficiency of getting the RNAi probe inside the cell and the 
RNA sequence can affect the achieved reduction in protein expression, among other factors 
[19]. In order to limit false positives and false negatives in the fluorescence measurements, 
RNAi probes for the target proteins were chosen based on their use in previous RNAi 
screens, thermodynamic binding efficiency and selectivity for the target protein [40]. Based 
on a trypan blue assay, there is no change in cell viability after any of the RNAi treatments 
[31,40].  
RT PCR confirmed statistically significant reductions in mRNA concentrations after 
RNAi treatment for all target proteins (Table 1). The largest reduction was measured for 
actin 42A (90 to 92%) and the smallest reduction was for paxillin (25 to 43%). Reduction of 
one component of the trimeric protein complex consisting of ILK, pinch (the vertebrate 
homolog to steamer duck), and parvin may cause partial degradation of the other components 
within the complex via a proteasome-mediated process, which would not be reflected in the 
RT PCR data [24]. RNAi selectivity for these proteins may be low.  
There were no statistically significant changes in the mRNA concentration for the 
βPS integrin subunit after RNAi treatment for any of the target cytoplasmic proteins included 
in this study (data not shown). Supporting the RT-PCR data, the αβ-Venus fluorescence 
intensity in the cell membrane was statistically similar in cells before and after RNAi 
treatment for all target proteins (data not shown). Comparable αβ-Venus fluorescence 
intensities among all treatments indicate that the membrane integrin concentration is not 
significantly perturbed upon reducing the expression of the target cytoplasmic proteins.  
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Changes in integrin diffusion at reduced cytoplasmic protein concentrations  
Integrin FRAP curves from replicate measurements were collected after RNAi 
treatment against nine cytoplasmic proteins (Fig. 2). As shown in Table 1, for all curves 
except rhea, focal adhesion kinase and akt1, the model for time-dependent diffusion with an 
immobile fraction is the best fit. For rhea, focal adhesion kinase and akt1, the FRAP curves 
are fit equally well by the Brownian diffusion and time-dependent diffusion model, and 
similar diffusion parameters are obtained from both models. For these cytoplasmic proteins 
there are no or fewer diffusion constraints after reducing their expression. 
Table 2 shows the measured diffusion parameters obtained from the FRAP curves for 
cells that were RNAi treated for the indicated cytoplasmic protein. In subsequent discussion 
all values for the RNAi treated cells are compared to the control value for cells spread on a 
ligand coated surface. In general, two changes to integrin diffusion occur after reducing the 
concentration of the targeted cytoplasmic proteins.  For a subset of proteins (actin 42A, 
dreadlocks, paxillin, ILK, vinculin) integrin diffusion generally slows at longer times with an 
increase in the integrin mobile fraction.  This indicates that when these proteins are expressed 
at native concentrations integrin diffusion is less constrained. For a second subset of proteins 
(rhea, FAK) the opposite trend is observed. This indicates that these proteins result in more 
constrained diffusion when they are expressed at endogenous levels. After steamer duck 
RNAi, there is no statistically significant change in the integrin diffusion coefficient, but the 
mobile fraction decreases. RNAi against akt1 increases the integrin mobile fraction and 
results in Brownian diffusion with an overall slower diffusion coefficient. 
Cells were spread on a ligand coated microscope slide for all FRAP measurements 
performed after the RNAi treatments.  When the expression of actin 42A is reduced, the 
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profile of integrin diffusion mimics that measured for cells spread on a microscope slide in 
the absence of ligand (Table 2). At reduced actin 42A concentrations or in the absence of 
ligand there is a ~ 25% increase in the integrin mobile fraction and a 50 to 70% decrease in 
the diffusion coefficient at long analysis times. In human osteosarcoma and mouse 
embryonic fibroblast cells no direct physical interaction takes place between integrin and 
actin proteins, as measured with a sub-diffraction fluorescence imaging technique [41]. The 
integrin cytoplasmic tail and actin are separated by approximately 40 nm. Within the 
intervening region several adapter proteins are found (e.g. FAK, paxillin, rhea, vinculin).  
Reduced expression of paxillin or vinculin mimics the changes in integrin diffusion measured 
when actin 42A expression is reduced. Whereas reducing the expression of rhea and FAK 
has the opposite effect as reducing the expression of actin 42A.  
A key function of rhea is to connect ligand-bound integrin to the actin cytoskeleton, 
but rhea is not required for integrin binding to ligand. Talin, the vertebrate homolog to rhea, 
has a role in the avidity regulation of integrins [42]. Increased integrin clustering in the 
presence of rhea may explain why reduced rhea concentrations result in Brownian diffusion 
with a faster diffusion coefficient. The αβ-Venus fluorescence images before RNAi 
treatment do not show integrin clusters that are larger than the diffraction limit of light. The 
Saffman-Delbrück equation predicts that the integrin clusters would only have to contain a 
few proteins at endogenous rhea concentrations (i.e., smaller than the diffraction limit of 
light) to result in the approximately 30% increase in integrin diffusion measured after 
reducing the concentration of rhea. When the expression of ILK is reduced by RNAi there is 
a two-fold increase in integrin clusters that are smaller than the diffraction limit of light 
(manuscript in preparation). It is not known if existing clusters increase in size or if more 
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clusters develop. The Saffman-Delbrück equation predicts a 20 to 40% decrease in the 
diffusion coefficient when integrin clusters double in size, but remain smaller than the 
diffraction limit of light. The measured change in integrin diffusion after reducing the 
expression of ILK could be the result of increased integrin clustering.  
A recent paper has shown that reducing levels of vertebrate talin in a fibroblast cell 
line affected FAK signaling during cell spreading on fibronectin [43]. Total FAK levels did 
not change, but levels of phosphorylated Tyr397 were attenuated in talin depleted cells.  
Altered FAK signaling may be the mechanism for altered integrin diffusion upon reducing 
rhea expression.  Evidence supporting this hypothesis is the fact that similar changes in 
integrin diffusion were measured after reducing the expression of rhea or FAK (6.2-7 x 10-9 
cm2/sec Brownian diffusion with a reduced mobile fraction).  
Correlations measured between integrin diffusion and lipid diffusion 
 In order to determine if changes in integrin diffusion are the result of overall changes 
in membrane viscosity, lipid diffusion coefficients were measured after RNAi treatment for 
the same target proteins. The cell line used for these measurements expressed wild-type 
integrin and had a fluorescent carbocyanine lipid mimetic incorporated into the cell 
membrane. For all lipid fluorescence recovery curves (Electronic supplementary material 
Fig. S2) except actin 42A and dreadlocks, the data were fit by the Brownian diffusion model 
or the constrained diffusion with an immobile fraction model generated a time exponent 
close to 1 (Table 1 and 3).  
Two significant changes are observed in the diffusion of the fraction of lipid 
represented by DiD after individually reducing the concentration of nine cytoplasmic 
proteins.  Reducing expression of dreadlocks, paxillin, FAK and ILK results in a 13 to 21% 
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increase in the lipid mobile fraction. Dreadlocks RNAi is the only one among this list that 
shows a consistent change between lipid and integrin mobile fractions. Second, lipid 
diffusion is constrained with an approximately 20% decrease in the time exponent when the 
expression of actin 42A and dreadlocks are reduced. This increase in constrained diffusion 
parallels the change measured for integrin diffusion when the expression of these proteins are 
reduced. This suggests that actin 42A and dreadlocks have a role in overall membrane 
organization and fluidity. Actin has been shown to affect lipid phase segregation, which 
indicates a possible functional role in altering lipid nanodomains [44]. Under some 
conditions lipid nanodomain formation is reduced in the presence of actin.  This is consistent 
with the RNAi results indicating more constrained lipid diffusion in the absence of actin 
42A. With these exceptions, altered integrin diffusion after reducing the expression of the 
other cytoplasmic proteins is not the result of global changes in membrane viscosity.  
Theory for the mechanism of altered integrin diffusion 
 The combined data in the absence of ligand and after reducing the expression of 
cytoskeletal proteins indicate that breaking the ECM-integrin-cytoskeletal connection has a 
role in altering integrin dynamics. There are multiple modes of association between integrins 
and the cytoskeleton. Some of these interactions constrain diffusion while others release 
diffusion constraints (Fig. 3). Integrins have been shown to partition between nanodomains 
and the bulk membrane in response to a variety of stimuli including ligand binding [45]. The 
most likely explanation for how reduced expression of cytoplasmic protein alters the 
constraints to integrin diffusion is altered partitioning between nanodomains and bulk 
membrane. In some instances integrin clustering may be a separate mechanism or may be the 
result of partitioning into (e.g., ILK RNAi) or out of (e.g., rhea RNAi) nanodomains. With 
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the exception of Akt1, (1) Brownian diffusion is associated with lower mobile fractions while 
(2) constrained diffusion is associated with higher mobile fractions. (1) If the integrins are 
confined in nanodomains and do not escape on the time scale of the FRAP experiment, the 
immobile fraction increases while the remaining integrins in the bulk membrane have fewer 
restrictions to diffusion. (2) If the integrins partition between nanodomains and the bulk 
membrane on the time scale of the FRAP experiment and/or the nature of the nanodomains is 
altered on this time-scale, then the mobile fraction increases but diffusion is constrained. The 
nature of these nanodomains is not known at this time, but may include heterogeneous 
populations of lipid and proteins that associate with the cytoskeleton or are formed via 
interactions with the cytoskeleton. Future studies where the size of the photobleached area is 
altered may reveal if the mobile integrin is dependent on membrane nanodomains and 
selective extraction of membrane components may reveal the composition of these domains.   
 In no case does altering the ECM-integrin-cytoskeletal connection by the means 
employed herein lead to unrestricted lateral integrin diffusion predicted by the Saffman-
Delbrück equation.  The ECM-integrin-cytoskeletal linkage is not completely dissociated and 
high concentrations of membrane protein are present. Simultaneously reducing the 
expression of multiple cytoplasmic proteins, including proteins that may not have been 
included in this study, as well as eliminating integrin interactions with other membrane 
proteins may be required to achieve unrestricted integrin diffusion. Additionally, complete 
elimination of the target protein expression may have a greater impact on integrin diffusion 
than reported in Table 3. Complete elimination of protein expression by RNAi is rarely 
achieved; still the other methods that can be used to alter protein expression are generally 
time consuming compared to the RNAi approach. Comparing all RNAi targeted proteins, 
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there is no correlation between the magnitude of mRNA reduction and the magnitude change 
in integrin diffusion coefficients. However, correlations between protein expression and 
integrin diffusion may be correlated [46]. 
 
SUMMARY 
The combination of FRAP and RNAi can be used to elucidate the molecular 
mechanism of integrin lateral diffusion. The use of RNAi to reduce the expression of a single 
protein enables the measurement of that protein's contribution to alterations in integrin 
diffusion. This is in contrast to several other methods where the entire cytoskeletal 
composition is altered or the target protein must directly bind with the integrin so that the 
interaction can be disrupted with integrin mutants. Integrins are linked to the cytoskeleton 
through a network of proteins, which is more than a simple anchor to the membrane. Diverse 
connections have functional significance in terms of altering integrin dynamics. This in turn 
affects the ability of integrins to move to different locations on the cell membrane in 
response to stimuli. For the most part, the mechanism by which the indicated cytoplasmic 
proteins alter integrin diffusion is more complex than simple changes in lipid viscosity, and 
partitioning of integrins into nanodomains is hypothesized to be the main factor affecting the 
mode of integrin diffusion upon altering the ECM-integrin-cytoskeletal connection. The 
combination of FRAP and RNAi should be suitable to study the diffusion of other 
fluorescently labeled membrane proteins and will be useful for unraveling the molecular 
mechanism of membrane dynamics. 
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Table 1. Real-time polymerase chain reaction results and reduced chi2 values obtained from 
integrin (top number) or lipid (bottom number) FRAP curves fit to different diffusion models 
before (control ligand or control no ligand) and after the indicated RNAi treatments 
 
 
Constrained 
Diffusion 
chi2 
 
Brownian 
Diffusion 
chi2 
Time-dependent 
diffusion with an 
immobile fraction 
chi2 
Percent 
reduction in 
mRNA  after 
RNAia 
Control ligand 4.7 5.8 
1.3 
1.1 
1.2 
1.1  
Control no 
ligand 
3.0 
4.1 
1.5 
1.4 
1.0 
1.5  
Actin 42A 2.2 3.6 
2.5 
1.4 
1.4 
1.0 
90-92 
 
Dreadlocks 4.6 3.5 
4.7 
2.5 
4.0 
1.0 38-76 
Paxillin 4.4 2.1 
1.2 
1.4 
1.0 
1.3 25-43 
Integrin 
Linked Kinase 
1.5 
1.9 
1.2 
1.8 
1.0 
1.9 59-73 
Vinculin 2.6 1.9 
1.6 
0.4 
1.4 
0.4 84-90 
Akt1 2.6 
3.2 
1.3 
0.9 
1.3 
1.0 
76-80 
Rhea 3.5 
3.4 
0.9 
0.4 
0.9 
0.4 
32-63 
Focal Adhesion 
Kinase 
7.8 
2.2 
2.1 
0.9 
2.1 
1.0 78-92 
Steamer Duck 7.1 1.0 
2.0 
0.5 
1.8 
0.5 67-82 
a Measurements were performed in duplicate (n=2). Real time polymerase chain reaction 
results are expressed as a range that indicates a 95% confidence interval for expression ratios 
without normality or symmetrical distribution assumptions as determined using the software 
REST 2009. The p values for all entries in this column are 0.000 which indicates a 
statistically significant difference in mRNA concentration after RNAi treatment compared to 
the value measured before RNAi treatment. 
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Table 2. Integrin diffusion parameters obtained from the best-fit modela of the FRAP curves 
for a αβ-Venus cell line before (control ligand or control no ligand) and after the indicated 
RNAi treatments. 
a Mobile 
fraction 
Time 
exponent 
(α) 
Diffusion 
coefficient at 
1 s 
(x 10-9cm2/s) 
Diffusion 
coefficient 
at 50 sec 
(x 10-9cm2/s) 
Control 
Ligand 0.45 ± 0.02 0.90 ± 0.07 5.2 ± 0.9 3.6 ± 0.6 
Control 
No Ligand 0.70 ± 0.03 0.83 ± 0.05 4.1 ± 0.6 2.1 ± 0.2 
Actin 42A 0.70 ± 0.04 0.69 ± 0.06 5 ± 1 1.6 ± 0.2 
Dreadlocks 0.72 ± 0.05 0.75 ± 0.05 3.0 ± 0.7 1.1 ± 0.2 
Paxillin 0.49 ± 0.02 0.85 ± 0.06 4.6 ± 0.8 2.6 ± 0.3 
Integrin 
Linked Kinase 0.49 ± 0.05 0.7 ± 0.1 5 ± 1 1.6 ± 0.4 
Vinculin 0.54 ± 0.04 0.79 ± 0.09 7 ± 1 2.9 ± 0.6 
Akt1 0.60 ± 0.02 
 
3.1  ± 0.5b 
 
Rhea 0.28 ± 0.01 
 
7  ± 1b 
 
Focal Adhesion 
Kinase 0.28 ± 0.01  6.2
  ± 0.9b 
 
Steamer Duck 0.32 ±  0.01 0.87 ± 0.06 6.3 ± 0.9 3.9 ± 0.6 
a Brownian diffusion assumed to be the best-fit model if the reduced chi2 was the same for 
time-dependent diffusion with an immobile fraction and Brownian diffusion models 
b Brownian diffusion is not time-dependent (alpha = 1); diffusion coefficient will be the 
same value at all analysis times 
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Table 3. Lipid diffusion parameters obtained from the best-fit model to FRAP curves for a 
αβ cell line before (control ligand or control no ligand) and after the indicated RNAi 
treatments 
a Mobile 
fraction 
Time 
exponent 
(α) 
Diffusion 
coefficient at 1 s 
(x 10-9cm2/s) 
Diffusion 
coefficient at 50 s 
(x 10-9cm2/s) 
Control 
Ligand 0.80 ± 0.03 
1.1 ± 
0.1 30 ± 3
b 
 
Control 
No Ligand 0.80 ± 0.01  30 ± 2
b
 
 
Actin 42A 0.86 ± 0.06 0.8 ± 0.1 22 ± 3 12 ± 2 
Dreadlocks 1.01 ± 0.04 0.83 ± 0.07 26 ± 2 13 ± 1 
Paxillin 0.94 ± 0.02 0.96 ± 0.06 26 ± 2 22 ± 1 
Integrin 
Linked Kinase 0.96 ± 0.02  36 ± 2
b
 
 
Vinculin 0.87 ± 0.05 1.1 ± 0.2 34 ± 5  
Akt1 0.74 ± 0.04 
 
28 ± 4b 
 
Rhea 0.87 ± 0.05 1.0 ± 0.1 29 ± 3  
Focal Adhesion 
Kinase 0.93 ± 0.03  29 ± 2
b
 
 
Steamer Duck 0.82 ± 0.04 
1.0 ± 
0.1 31 ± 3  
a Brownian diffusion assumed to be the best-fit model if the reduced chi2 was the same for 
time-dependent diffusion with an immobile fraction and Brownian diffusion models  
b Brownian diffusion is not time-dependent (alpha = 1); diffusion coefficient will be the 
same value at all analysis times 
 
 Figure 1. Experimental approach
proteins and small molecules. The 
work are shown in the cell membrane in the absence of other membrane proteins for 
simplicity. Integrins are tagged with the Venus fluorescent protein
integrin diffusion properties are measured in cells with endogenous levels of cytoplasmic 
proteins. Integrins diffusion is described by a time
immobile fraction. 2 RNAi is used to reduce the expression of one cytoplasmic protein
Changes in the integrin diffusion properties are measured. These studies 
cytoplasmic proteins that have a role in altering integrin lateral diffusion in the cell 
membrane as further discussed in the text.
Venus integrins at three time points in the FRAP experiment. The 
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Figure 2. Average fluorescence recovery after photobleaching (FRAP) curves from replicate 
measurements (blue circles) for the S2 cell line expressing αPS2CβPS-Venus integrins at 
native cytoplasmic protein concentrations: a cells spread on ligand coated slide, b cells 
spread in the absence of ligand; and after the following RNAi treatments for cells spread on a 
ligand coated slide: c Actin 42A; d Dreadlocks; e Paxillin; f ILK; g Vinculin; h Akt1; i Rhea; 
j FAK and k Steamer duck. The data are either fit to a model that accounts for time-
dependent diffusion with an immobile fraction (a-g and k) or a Brownian diffusion model (h-
j) (red line).  All curves have been normalized to the pre-photobleach intensity.  
 
  
 Figure 3. Proposed model for the regulation of integrin dynamics
cytoplasmic protein concentrations there is an immobile fraction and equilibrium between 
mobile integrins in the bulk membrane and in nanodomains. Upon altering the ECM
integrin-cytoskeletal connection this equilibrium is disrupted. In some cases immobile 
integrins are confined in nanodomains and do not escape. At the same time the remaining 
integrins in the bulk membrane exhibit Brownian diffusion. In other cases, the integrins 
partition between nanodomains and the bulk membrane. This increases the mobile fraction, 
but diffusion is constrained on the time scale of the FRAP experiment.
 
 
 
. 
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Supporting Information for Chapter 2 
Figure S1. Integrin and lipid FRAP curves. Average experimental FRAP curve for αβ-
Venus cells spread on a ligand containing microscope slide (blue markers). The inset shows 
the same FRAP curve at longer analysis times. The data are fit to a model with time-
dependent diffusion plus an immobile fraction. Experimental FRAP curves for αβ cells 
labeled with the membrane fluorophore DiD spread on a ligand containing microscope slide 
(black markers). The data are fit to a model with Brownian diffusion. Theoretical FRAP 
curve for Brownian diffusion with a 1 x 10-7 cm2/sec diffusion coefficient (green line), the 
fastest diffusion that can be measured with the experimental method. 
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Figure S2. Average FRAP curves from replicate measurements for the S2 cell line 
expressing wild-type integrins and labeled with the membrane dye DiD (1,1'-dioctadecyl-
3,3,3',3'- tetramethylindodicarbocyanine perchlorate) at native cytoplasmic protein 
concentrations (A) cells spread on ligand coated slide, (B) cell spread in absence of ligand; 
and after the following RNAi treatments for cells spread on a ligand coated slide: (C) Actin 
42A; (D) Dreadlocks; (E) Paxillin; (F) ILK; (G) Vinculin; (H) Akt1; (I) Rhea; (J) FAK and 
(K) Steamer Duck. The data are either fit to a model that accounts for time-dependent 
diffusion with an immobile fraction (C-E) or a Brownian diffusion model (A, B,F-K) (red 
line). The diffusion coefficients and mobile fractions are listed in Table S2. All curves have 
been normalized to the pre-photobleach intensity. 
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Table S1. Integrin diffusion parameters obtained by fitting FRAP curves to constrained (time 
dependent) diffusion, Brownian diffusion and time-dependent diffusion with an immobile 
fraction models for a cell line expressing αPS2CβPS-Venus integrins before (control) and 
after the indicated RNAi treatment. The fit parameters from the best-fit model, either time 
dependent diffusion with an immobile fraction or Brownian diffusion, are shown in Table 2 
of the manuscript. The control cells were measured for cells spread on an integrin ligand 
containing microscope slide (ligand) or a slide containing only the protein BSA (no ligand). 
After RNAi treatment the cells are spread on a ligand coated microscope slide.  
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 
α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
Mobile 
fraction 
Diffusion 
Coefficient 
(x10-9cm2/s) 
Mobile 
Fraction α 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Control 
Ligand 
0.38 
± 0.01 
5.3 
± 0.4 
0.46 
± 0.01 
0.43 
± 0.01 
4.3 
± 0.6 
0.45 
± 0.02 
0.90 
± 0.07 
5.2 
± 0.9 
3.6 
± 0.6 
Control 
No Ligand 
0.54 
± 0.01 
4.9 
± 0.2 
0.81 
± 0.02 
0.63 
± 0.01 
3.0 
± 0.4 
0.70 
± 0.03 
0.83 
± 0.05 
4.1 
± 0.6 
2.1 
± 0.2 
Actin 42A 0.48 
± 0.02 
5.1 
± 0.3 
0.67 
± 0.02 
0.56 
± 0.01 
3.1 
± 0.4 
0.70 
± 0.04 
0.69 
± 0.06 
5 
± 1 
1.6 
± 0.2 
Dreadlocks 0.57 
± 0.01 
3.1 
± 0.2 
0.58 
± 0.01 
0.59 
± 0.01 
1.9 
± 0.3 
0.72 
± 0.05 
0.75 
± 0.05 
3.0 
± 0.7 
1.1 
± 0.2 
Paxillin 0.41 
±0.01 
4.6 
± 0.3 
0.47 
± 0.01 
0.45 
± 0.01 
3.5 
± 0.5 
0.49 
±0.02 
0.85 ± 
0.06 
4.6 
± 0.8 
2.6 
± 0.3 
ILK 0.42 
± 0.03 
3.6 
± 0.6 
0.37 
± 0.02 
0.40 
±0.02 
2.9 
± 0.5 
0.49 
±0.05 
0.7 
± 0.1 
5 
± 2 
1.6 
± 0.4 
Vinculin 0.39 
± 0.02 
6.2 
± 0.6 
0.57 
± 0.03 
0.48 
± 0.02 
4.5 
± 0.7 
0.54 
± 0.04 
0.79 
± 0.09 
7 
± 1 
2.9 
± 0.6 
Akt1 0.52 
± 0.02 
4.8 
± 0.4 
0.73 
± 0.03 
0.60 
± 0.02 
3.1 
± 0.4 
0.64 
± 0.04 
0.89 
± 0.08 
3.8 
± 0.9 
2.5 
± 0.4 
Rhea 0.28 
± 0.02 
4.1 
± 0.7 
0.25 
± 0.02 
0.28 
± 0.01 
7 
± 1 
0.27 
± 0.02 
1.1 
± 0.1 
5.8 
± 2 
8.6 
± 3 
FAK 0.28 
± 0.01 
4.1 
± 0.4 
0.25 
± 0.01 
0.28 
± 0.01 
6.2 
± 0.9 
0.28 
± 0.01 
0.97 
± 0.08 
6.5 
± 1 
5.9 
± 1 
Steamer 
Duck 
0.31 
± 0.01 
4.0 
± 0.3 
0.27 
± 0.01 
0.30 
± 0.01 
5.1 
± 0.7 
0.32 
±  0.01 
0.87 
± 0.06 
6.3 
± 0.9 
3.9 
± 0.6 
 
a Diffusion parameters were obtained from fitting the average FRAP curve of replicate 
measurements with the standard deviation representing the uncertainty at the 95% confidence 
interval of the corresponding coefficients obtained in the fits. 
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Table S2. Lipid diffusion parameters obtained by fitting FRAP curves to constrained (time 
dependent) diffusion, Brownian diffusion and time-dependent diffusion with an immobile 
fraction models for a cell line expressing αPS2CβPS integrins before (control) and after the 
indicated RNAi treatment. The fit parameters from the best-fit model either Brownian 
diffusion or time dependent diffusion with an immobile fraction, are shown in Table 3 of the 
manuscript. The control cells were measured for cells spread on an integrin ligand containing 
microscope slide (ligand) or a slide containing only the protein BSA (no ligand). After RNAi 
treatment the cells are spread on a ligand coated microscope slide. 
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 
α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
Mobile 
fraction 
Diffusion 
Coefficient 
(x10-9cm2/s) 
Mobile 
Fraction α 
Diffusion 
Coefficien
t 
(1 s) 
(x10-
9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Control 
Ligand 
0.60  
± 0.03 
22  
± 1 
4.6  
± 0.3 
0.81  
± 0.03 
30  
± 3 
0.80 
± 0.03 
1.1 
± 0.1 
30 
± 3 
37  
± 4 
Control 
No Ligand 
0.57  
± 0.01 
22  
± 1 
4.1  
± 0.1 
0.80  
± 0.01 
30  
± 2 
0.80 
± 0.02 
1.0 
± 0.1 
 30 
± 2 
30  
± 2 
Actin 42A 0.61  
± 0.03 
19  
± 1 
4.1  
± 0.3 
0.81  
± 0.03 
23  
± 3 
0.86 
± 0.06 
0.8 
± 0.1 
22 
± 3 
12 
± 2 
Dreadlocks 0.88  
± 0.02 
27  
± 1 
17 
± 0.9 
0.95  
± 0.02 
28  
± 2 
1.01 
± 0.04 
0.8
3 ± 
0.07 
26  
± 2 
13  
± 1 
Paxillin 0.71  
± 0.04 
28  
± 1 
8.0 
± 0.3 
0.92  
± 0.02 
27  
± 1 
0.94 
± 0.02 
0.9
6 ± 
0.06 
26  
± 2 
22  
± 1 
ILK 0.68  
± 0.03 
32  
± 1 
9.3  
± 0.3 
0.96  
± 0.02 
36  
± 2 
0.96 
± 0.02 
1.0
1 ± 
0.06 
36  
± 2 
37  
±  
Vinculin 0.63  
± 0.03 
29  
± 2 
6.6  
± 0.6 
0.89  
± 0.04 
34  
± 5 
0.87 
± 0.05 
1.1 
± 0.2 
35  
± 5 
47  
± 6 
Akt1 0.81  
± 0.02 
15  
± 2 
6.9  
± 0.9 
0.74  
± 0.04 
28  
± 4 
0.73 
± 0.05 
1.1 
± 0.2 
28  
± 5 
35  
±  
Rhea 0.52  
± 0.04 
25  
± 2 
3.8  
± 0.2 
0.86  
± 0.03 
29  
± 3 
0.87 
± 0.05 
1.0 
± 0.1 
29  
± 4 
24  
± 3 
FAK 0.81  
± 0.03 
26  
± 2 
12  
± 0.8 
0.93  
± 0.03 
29  
± 2 
0.93 
± 0.03 
0.9
8 ± 
0.08 
29  
± 3 
27  
± 2 
Steamer 
Duck 
0.85  
± 0.02 
22 
± 2 
12  
± 1 
0.83  
± 0.03 
31  
± 3 
0.82 
± 0.04 
1.0 
± 0.1 
31  
± 4 
37  
± 4 
 
a Diffusion parameters were obtained from fitting the average FRAP curve of replicate 
measurements with the standard deviation representing the uncertainty at the 95% confidence 
interval of the corresponding coefficients obtained in the fits. 
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CHAPTER 3: NON-INVASIVE LIVE CELL MEASUREMENTS OF 
RECEPTOR CLUSTERING ALTERED BY INTRACELLULAR 
PROTEINS  
Suzanne Sander, Deepak Dibya, Emily A. Smith 
Department of Chemistry, Iowa State University, 1605 Gilman Hall, Ames, Iowa 50011 
ABSTRACT  
 The role of select cytoplasmic proteins in altering integrin receptor clustering on the 
nanoscale in the presence of extracellular ligand binding is reported. Integrin clustering was 
measured using fluorescence resonance energy transfer (FRET) combined with RNA 
interference (RNAi), which is used to reduce the expression of a select cytoplasmic protein. 
Membrane spanning FRET reporter peptides that cluster with the integrin are used as a non-
invasive probe of receptor clustering on the nanoscale. A change in energy transfer after 
reducing the expression of a cytoplasmic protein provides quantitative information about the 
protein’s role in receptor clustering. Cytoplasmic proteins involved in wild-type and mutant 
integrin clustering have been identified for cells spread on a surface with 40 ± 10% ligand 
density. The RNAi targeted proteins in this study include: dreadlock, integrin linked kinase, 
paxillin, steamer duck, vinculin, rhea, focal adhesion kinase, and Rho1.The RNAi protocol 
used in these studies targets at least 38% of the cells in a culture, which is sufficient to 
produce a measurable change in energy transfer for at least a subset of RNAi targeted 
cytoplasmic proteins due to altered integrin clustering. Experiments were performed with 
control FRET peptides to ensure that the energy transfer values measured with FRET 
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reporters correlate with integrin clustering, and are not the result of non-integrin dependent 
cell membrane properties.  
 
INTRODUCTION 
The transmission of information between cells and their environment is necessary for 
survival, growth, mobility, and other fundamental aspects of development [1]. Receptor cell 
membrane proteins are intermediaries in the transmission of information across the cell 
membrane. Membrane spanning integrins are receptors that consist of non-covalently 
interacting α and β subunits. Integrins bind to both intracellular and extracellular proteins. 
Outside-in signaling is initiated by ligand binding to the extracellular domain, while inside-
out signaling requires the interaction of adapter proteins with the integrins cytoplasmic tails 
[1,2]. There are dozens of intracellular proteins that have been shown to interact with integrin 
cytoplasmic domains, including rhea[3], integrin linked kinase [4] and paxillin [5].  
Individually, integrins have a low binding affinity for ligand (µM-1 to mM-1)[6]; 
however, their high concentration in the membrane and their ability to cluster enables the 
strong adherence of cells to the extracellular matrix. Characterization of integrin clustering is 
performed in two different spatial regimes: larger or smaller than the diffraction limit of 
light, approximately 200 nm. Currently, non-invasive methods for measuring clusters smaller 
in size than 200 nm in live cells are limited, and dynamic integrin interactions within the cell 
membrane are poorly understood. Fluorescence resonance energy transfer (FRET) [7] is a 
technique that can measure clustering on a scale of 10 nm or less. A non-invasive FRET 
assay of receptor clustering would not require the direct attachment of donor and acceptor 
FRET pairs to the receptor.  
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FRET has been previously applied to study integrin clustering [8-11]. One study used 
FRET reporter peptides instead of direct fluorophore attachment onto the receptor. The 
FRET reporter peptides spanned the membrane, clustered with the integrins without altering 
integrin-ligand binding and were developed by attaching fluorescent proteins to the β 
subunit’s transmembrane and cytoplasmic domain. This FRET assay also eliminated time 
consuming protein cloning steps for receptor mutant studies [8]. 
Reported herein is the use of this previously reported FRET assay to identify how 
intracellular proteins affect integrin clustering. The effects of vinculin, paxillin, focal 
adhesion kinase, rhea, integrin linked kinase, dreadlock, and steamer duck on the clustering 
of αPS2CβPS integrins have been measured in S2 cells spread on a surface with 40 ± 10% 
ligand density, and these effects are compared to results obtained from studies that utilized a 
lower ligand density [12-15]. Specific amino acid contacts between the 
transmembrane/cytoplasmic domains are likely to drive the co-clustering of the integrins and 
FRET reporters [16].  Additionally, the quantitative measurement of integrin and FRET 
reporter expression levels is reported for the first time.  
 
EXPERIMENTAL 
Cells Lines 
 All experiments were performed using Drosophila S2 cells cultured in Shields and 
Sang M3 medium (M3, Sigma) with antibiotics, streptomycin and penicillin, 10% fetal calf 
serum (FCS), and methotrexate. Detailed culture protocols have been described elsewhere 
[17]. Cells were transformed to express wild-type integrins [18], mutant integrins [18], FRET 
reporters[8], FRET controls [8] or a combination therein.   
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RNAi treatment 
Double stranded RNA (dsRNA) was synthesized as described previously[19,20].Proteomics 
databases were used to confirm that target proteins are expressed in Drosophila S2 cells 
[21,22]. Cells were plated in a culture dish at a concentration of 1 x 106 cell/mL. The cells 
were rinsed with serum free M3 medium, and then 300 µL serum free M3 medium was added 
to each well. Ten micrograms of dsRNA was added to each well. The cells were incubated 
with dsRNA in serum free medium for 60 minutes at 22˚C. Subsequently, 300 µL of M3 
medium containing 20% FCS was added to the wells. The cells were incubated for 4 days at 
22˚C. Then the cells were placed in a water bath set to 36˚C for 30 minutes to induce the 
expression of integrins, FRET reporters and FRET controls, which are cloned in heat shock 
plasmids. The cells were placed in a 22˚C incubator for 3 hours. The cells (200 µL) were 
centrifuged at 600 g for 3 minutes, re-suspended in 300 µL of M3 medium, counted and 
diluted to a final concentration of 3 x 105 cells/mL. For all measurements, 50 µL of cells 
were plated into each well of a ligand coated slide. A recombinant version of the αPS2CβPS 
integrin’s ligand (0.025 µg) was used for these studies, as previously described [23]. The 
cells were allowed to spread in the dark for 1 hour. During this time, the S2 cells spread to 
their maximum level and no further spreading or cell movement can be measured. The 
medium was then removed and replaced with 20 mM BES Tyrodes buffer.  
Protein Expression Levels 
Expression of αPS2CβPS integrin was measured via flow cytometry as previously 
reported [8]. Expression of extracellular Venus fluorescent protein was similarly measured 
by flow cytometry. Briefly, 0.5 x 106 cells were centrifuged and then resuspended in 50 µl 
green fluorescent protein (GFP) antibody (Invitrogen) diluted 1:500 (v/v) in M3+FCS, and 
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placed on ice for 30 minutes. This antibody also binds to yellow fluorescent protein variants. 
Subsequently, the cells were spun down and resuspended in 50 µL anti-mouse labeled with 
phycoerythrin (Invitrogen) diluted 1:300 (v/v) in M3+ FCS, and put on ice for an additional 
30 minutes. The cells were spun down and resuspended in 2% paraformaldehyde prior to 
analysis on a BD FACScan flow cytometer. 
Fluorescence Measurements 
 All fluorescence microscopy measurements were made with an Eclipse TE2000U 
microscope (Nikon) with a 60x, 0.95 numerical aperture objective and a mercury lamp 
excitation source. Images were captured via a Coolsnap CCD camera (Roper 
ScienfiticPhotmetrics, Pleasanton, CA) set to bin 8x8 pixels. Image capture was controlled 
using the program Micromanager, which operates in ImageJ 1.37v software (NIH). Each cell 
was imaged using three different filters: donor filter set with an excitation of 500/20 nm and 
an emission of 535/30 nm; acceptor filter set with an excitation of 545/30 nm and an 
emission of 620/60 nm; and FRET filter set which combines the donor excitation filter with 
acceptor emission filter. The exposure times for the donor, acceptor, and FRET images were 
6, 6, and 12 seconds, respectively.   
FRET Data Analysis 
In comparison to previous studies using FRET reporters, calculations of energy 
transfer in this study enable a quantitative measure of the concentration of interacting 
donor/acceptor pairs on the reporter peptides. Data was analyzed using a plug-in developed 
for ImageJ. The plug-in subtracts a background value and then calculates a FRET value using 
equation 1 [24]: 
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where IDA, IAA, and IDD are intensities obtained from the images with the FRET, acceptor, 
and donor filters, respectively. The G term is described below. The equation accounts for 
bleed-through of acceptor into the FRET filters, acceptor into the donor filters, donor into the 
acceptor filters, and donor into the FRET filters, using factors a, b, c, and d, respectively. For 
each analyzed cell, a region of interest is defined that excludes pixels corresponding to 
nuclear and surrounding regions [11]. One FRET value is obtained for each cell by averaging 
all pixels in the region of interest. Only cells spread to 20 µm in diameter or greater were 
analyzed. 
G Factor 
 The G factor in equation 2 correlates the decrease in donor fluorescence with an 
increase in acceptor fluorescence due to energy transfer[25]. The equation for G is: 
DDDDD
DAAAA
tSLQ
tSLQG =   (2) 
where QA and QD are the quantum yield of the acceptor and donor; LA and LD are the 
throughput of the acceptor and donor emission light path, SA and SD are the quantum 
sensitivity of the camera for the acceptor and donor emission and tDA and tDD are the 
exposure times for the FRET and donor filter sets, respectively. G can be measured 
experimentally using fixed (i.e., static)cells [24];however, formaldehyde fixation 
significantly alters the photophysical properties of the fluorescent proteins used in these 
studies. Instead, G was calculated using equation 2 and known system parameters. The 
quantum efficiency for the acceptor fluorescent protein, Cherry[26], is 0.22 and the quantum 
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efficiency for the donor fluorescent protein, Venus[27], is 0.57. The acquisition times using 
the FRET and donor filters are 12 and 6 seconds, respectively. The quantum efficiency of the 
detector was obtained by integrating the detector’s quantum efficiency curve over all 
wavelengths transmitted in the donor or acceptor’s emission filter for SD or SA, respectively. 
Similarly, LA and LD were determined by integrating the transmission curves over all 
emission wavelengths for the dichroic mirror and emission filters in the acceptor filter set 
(LA) or donor emission set (LD). G was calculated to be 1.419 for this experimental 
configuration. 
Statistical Analysis 
 Statistical analysis was accomplished via the program JMP 7 (SAS Institute Inc, 
Cary, USA) and statistical consulting from Iowa State University Department of Statistics. 
All data points represent 100 independent measurements from 3 replicate experiments. In 
order to statistically compare the raw FRET data, which is not normally distributed, the data 
was transformed to obtain a normal distribution [28]. This was done by taking the natural log 
of the raw data. The means were then calculated from the transformed data. The variances of 
some data sets from this study are not statistically similar as determined by Levene’s test so 
the Welch t-test was used to compare the means. The FRET data is reported in the original 
data scale by taking the antilog of the mean of the log transformed data, as discussed in 
statistics text books [29]. A p-value lower than 5% indicates that there is a statistically 
significant difference between the FRET data from the RNAi treatment and cells that 
received no RNAi treatment. If the p-value is greater than 5%, there is not enough evidence 
to conclude that the two groups are different.  
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RESULTS AND DISCUSSION  
FRET Assay 
The method for measuring the effects of cytoplasmic proteins in altering the 
clustering of integrins in live cells is shown in Figure 1. RNAi selectively reduces the 
expression of a cytoplasmic protein and FRET is subsequently measured via reporter 
peptides. FRET reporters contain the donor fluorescent protein Venus and the acceptor 
fluorescent protein Cherry, and are known to cluster when integrins cluster within the cell 
membrane[8]. Clustering of the FRET reporters results in a decrease in the separation 
distance between donor and acceptor fluorescent proteins and an increase in measured energy 
transfer (Figure 1B). Similarly, a decrease in integrin clustering results in an increased 
separation distance between the FRET reporter peptides, and a decrease in energy transfer 
(Figure 1C). 
FRET Reporter Expression Levels 
The expression levels of integrins and FRET reporters in the cell membrane were 
measured using antibodies and flow cytometry. There is no known antibody that will bind 
both the FRET reporter and the integrin; therefore, four measurements were required to 
ensure a direct comparison of expression levels: (i) integrin antibody binding to a cell line 
expressing wild-type integrin; (ii) integrin antibody binding to a cell line expressing Venus 
fluorescent protein inserted into the integrin’s beta subunit (αβ-Venus); (iii) fluorescent 
protein antibody binding to the same cell line in (ii); and (iv) fluorescent protein antibody 
binding to a cell line expressing wild-type integrins and FRET reporter Venus. This multi-
step experiment is required since the amount of antibody that binds to its antigen is specific 
to each antibody, and comparing the binding of integrin antibody to the binding of 
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fluorescent protein antibody may not reflect true expression levels. The GFP antibody was 
used to assess Venus expression levels since the molar absorptivity and quantum yield of the 
Venus fluorescent protein can be differentially altered upon attaching it to the integrin or the 
FRET reporter, which would not reflect true expression levels.  
Table 1 reports the expression ratios obtained from the four measurements described 
above. The values in rows 1 and 2 are multiplied and then divided by 2 to obtain the 
relationship listed in row 3. Division by a factor of 2 assumes equal expression of both 
Cherry and Venus FRET reporters, since the fluorescent protein antibody only binds to 
Venus (i.e., assumed to be one-half of the FRET reporters).After the expression ratio for the 
wild-type integrin and FRET reporter was measured, further considerations were made for 
the differential expression of mutant integrins used in this study (rows 4-5); as well as, for 
FRET control peptides (row 6). These cell lines will be discussed in further detail below. The 
expression ratio between FRET reporters and integrins was found to be 1:1.3 to 1:3.9. The 
ratio varied, not only from cell line to cell line, but also from cell to cell within the same cell 
line. The integrin:FRET reporter expression ratio cannot be controlled. 
The presence of FRET reporters may appear to be problematic since the intracellular 
domain of the FRET reporter is the same as the beta subunit’s intracellular domain, and may 
compete with a limited concentration of intracellular proteins. This would perturb the 
measurement of intracellular proteins that affect integrin clustering. However, this is not 
likely to be the case. A shift in the equilibrium binding of intracellular proteins to the 
integrins would alter the integrins' conformation and/or affinity for ligand [30]. Previously 
published results indicate that the integrins' ligand affinity is not altered by the presence of 
the FRET reporters[8]. 
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 It is possible that the intracellular domain of the FRET reporter does not have the 
required conformation for binding to intracellular proteins. The integrin extracellular domain, 
which the FRET reporters lack, is required to alter the conformation of the transmembrane 
and cytoplasmic domains [31]. 
Integrin Clustering in the Presence of Extracellular Ligand at Native Cytoplasmic 
Protein Concentrations 
Fluorescence microscopy is used to obtain spatially-correlated energy transfer data. 
This allows certain regions of the cell to be analyzed, as described in the experimental 
section. In order to measure energy transfer in a microscopy format, the cells must be spread 
on a bare or ligand coated substrate. In this study, cells were spread on a ligand coated 
surface. The ligand used was a recombinant protein containing the native ligand’s integrin 
binding domain [32]. Assuming all of the ligand (25 nanograms) that is exposed to the glass 
slide (30 mm2) adheres to the glass [32,11], 40 ± 10% of the surface is coated with ligand. 
The mean FRET values for cells expressing wild-type or mutant integrins and FRET 
reporters were measured prior to RNAi treatment (Table 2). Protein mutants can be used to 
elucidate the molecular mechanism of protein function. Two well-studied mutants are 
included in this study: anα cytoplasmic mutation (αanaβ) and a β extracellular domain 
mutation (αβV409D). The αanaβ mutation is near a site where cytoplasmic proteins are 
known to bind [33], and the αβV409D mutation is near the integrin’s ligand binding site 
[34]. Both integrin mutants exhibit increased affinity for ligand relative to wild-type 
integrin[18]. The energy transfer value calculated using equation 1, which is different than 
the equation used for previous studies involving the FRET report peptides, for cells 
expressing wild-type, αanaβ or αβV409D integrins and FRET reporters are statistically 
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similar, as indicated by a p-value that is above 0.05 (Table 2). This indicates similar amounts 
of integrin clustering in all cell lines prior to the RNAi treatments, within the assay’s 
detection limit.  Histograms of energy transfer measured for cells spread on a surface with 
no, low, or high ligand concentrations for all four cell lines used in these experiments are 
shown in Supplemental Information Figure S1.  
RNAi Transfection 
Drosophila S2 cells were used in this study because of the ease in selectively 
reducing the expression of a target protein via RNAi [19,35], the high degree of similarity 
between Drosophila and vertebrate integrins[36], and the fact that many of the integrin 
signaling pathways are conserved between invertebrate and vertebrate integrins[37]. 
Research has shown that information gained from integrin studies using Drosophila cells can 
translate to vertebrate systems[38]. 
The process of RNAi requires the cellular internalization of dsRNA corresponding in 
sequence to the target protein’s mRNA. The dsRNA for each target protein is referred to as 
an RNAi probe. The required information to generate RNAi probes for the entire Drosophila 
genome is available [39]. The RNAi probes utilized in this work have been previously 
described [11]. The amount a target protein’s expression is reduced depends on many 
variables, including the concentration of the target protein’s mRNA, the efficiency of the 
RNAi probe in crossing the membrane, and the thermodynamics of binding to the target 
mRNA. The reduced expression of mRNA was measured using real time polymerase chain 
reaction and showed reduction in mRNA ranging from ~25-90%. (Figure 2) [40].  
 Antibodies can be used to measure the presence of the target protein in the cell, as 
well as quantify protein expression [41]. Commercial antibodies are only available for some 
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of the targeted proteins in this study. Immunohistochemistry measurements were performed 
before and after RNAi for akt1, dreadlocks, vinculin, and paxillin.  The results showed a 26-
42% decrease in protein expression (Supplemental Information Figure S2).  The reduction in 
protein expression will differ for each targeted protein and each RNAi probe, but typical 
reductions in protein expression by RNAi for cultured Drosophila cells are between 62-100% 
[19,42]. 
 Two additional measurements of RNAi responses include quantify an actin 
fluorescent fusion protein and phenotypic analysis before and after RNAi treatment. An actin 
green fluorescent protein construct was used to measure a 21% reduction in actin expression 
in cells [11] (Supplemental Information Figure S2).  
 RNAi against a cytoplasmic protein that produces a visible phenotype when its 
expression is reduced, Rho1, was also used to demonstrate the efficient cellular delivery of 
dsRNA using the experimental protocol used in this study. An insufficient concentration of 
Rho1 results in cells containing 2 or more nuclei [15]. Four days after Rho1 RNAi, phase 
contrast microscopy images were taken of untreated (Information Figure S3A) and RNAi 
treated (Supplemental Information Figure S3B) cells expressing integrins and FRET controls. 
The percentage of cells that were multinucleate was measured for cells receiving three 
concentrations of dsRNA (Figure 2C). The results indicate that 10 µg/mL dsRNA, the 
concentration used for subsequent studies, produces an RNAi effect in at least 38% of the 
cells. These results should be considered a lower limit since it was not possible to determine 
if 2 or more nuclei were present in a small population of cells. More cells are affected when 
higher dsRNA concentration are used; however, deleterious effects occur with higher 
concentrations of dsRNA [43].Other RNAi probes in this study, which are between 200 and 
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570 base pairs, should cross the cell membrane with a similar efficiency as the Rho1 RNAi 
probe. 
Integrin Clustering in the Presence of Extracellular Ligand at Reduced Cytoplasmic 
Protein Concentrations  
The average FRET values for S2 cells expressing wild-type integrins and FRET 
reporters after the indicated RNAi treatment are presented in Table 3. Histograms of the data 
at different ligand concentrations are provided in Supplemental Information Figure S4. Since 
the goal of this work is to measure cytoplasmic proteins that alter integrin clustering when 
their expression levels are reduced, all data are normalized to the data point representing 
native expression levels (Table 2). A statistical comparison of the data with and without 
RNAi treatment indicates only ILK inhibition caused a statistically significant change in 
energy transfer when compared to cells receiving no RNAi treatment. A 2.5-fold increase in 
energy transfer was measured for the ILK depleted cells, which indicates a 2.5-fold increase 
in FRET reporter clustering after ILK expression is reduced.  The quantitative relationship 
between FRET reporter and integrin clustering is not known.  
Control experiments were performed to ensure that the measured change in energy 
transfer after ILK RNAi reflects alterations in integrin clustering, and is not a by-product of a 
change in another cell membrane property. FRET control peptides contain the same donor 
and acceptor fluorophore, but the membrane spanning and intracellular peptide sequence has 
no similarity to any protein found in the Drosophila proteome. If the change in FRET 
reporter clustering is integrin dependent, then no change in clustering is expected for the 
FRET control after the same RNAi treatment. Before RNAi treatment, statistically similar 
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levels of FRET reporter and FRET control clustering are measured using equation 1 to 
calculate FRET (Table 2).  
Cells expressing wild-type integrins and FRET control peptides showed no statistical 
difference in energy transfer after any RNAi treatments used in this study (Table 4). 
Histograms of the data at different ligand concentrations are provided in Supplemental 
Information S5. This indicates that the increase in energy transfer measured after RNAi 
treatment for ILK in the cell line expressing the FRET reporters is integrin specific. Under 
these experimental conditions, it can be concluded that ILK reduces integrin clustering, since 
reducing ILK expression results is increased integrin clustering. In comparison to previously 
published results, no statistically significant change in integrin clustering was measured after 
RNAi treatment for ILK in cells spread on a surface with 4 ± 1% ligand density [11]. This 
indicates that ILK only plays a role in altering integrin clustering if higher concentrations of 
extracellular ligand are present. These results highlight that the amount of integrin-ligand 
binding should be considered when making similar measurements of receptor clustering. 
Mutant Integrin Clustering in the Presence of Extracellular Ligand at Reduced 
Cytoplasmic Protein Concentrations  
The average FRET values for S2 cells expressing αβV409D integrins or αanaβ 
integrins and FRET reporters are shown in Table 4 after the indicated RNAi treatment. 
Histograms are shown in Figure S6 and S7. A few comparisons can be made between the 
values for the mutant and wild-type integrins. First, there are four RNAi treatments that result 
in less energy transfer in the cells expressing the mutant integrins. Vinculin, FAK, and ILK 
RNAi treatments for αβV409D and rhea RNAi treatment for αanaβ integrins show a 24 to 
44% statistically significant decrease in energy transfer compared to the no RNAi data set. 
65 
 
Since there is no statistically significant change in cells expressing the control peptides after 
these RNAi treatments (Table 3), the FRET reporters are measuring integrin specific 
changes. Decreased energy transfer values indicate there is less clustering of the FRET 
reporters and integrins when the expression of these cytoplasmic proteins is reduced. These 
proteins play a role in increasing integrin clustering in cells expressing these mutants when 
the cells are spread on a surface with a 40 ± 10% ligand density. 
 Continuing the comparison between the mutant and wild-type integrins, the αanaβ 
mutation shows an increase in energy transfer when paxillin and steamer duck expression is 
reduced, whereas none of the other cell lines shows a change in energy transfer with these 
RNAi treatments. This indicates there is a difference in the molecular mechanism of action of 
this protein mutant relative to the other integrins. It is likely that the α cytoplasmic mutation 
alters the interactions of this integrin with a subset of intracellular proteins [44]. It is not 
possible to say, at this point, that the alteration is the result of direct interactions with paxillin 
or steamer duck, or indirectly through other proteins.  
 A final distinction between the wild-type and mutant integrins is the difference 
between the increase in energy transfer for cells containing wild-type integrins after RNAi 
treatment for ILK and the decrease in energy transfer for the αβV409D mutation after the 
same RNAi treatment. The changes observed for these cell lines may relate to the integrin-
ligand affinity, which is from lowest to highest affinity: wild-type, αanaβ, and αβV409D. 
This trend is reversed for integrin clustering levels after RNAi treatment for ILK. Studies 
with additional integrin mutants are needed to test this hypothesis.   
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CONCLUSIONS 
When integrins bind to ligand, the result is an assemblage of cytoskeletal proteins that 
directly or indirectly bind to the integrin cytoplasmic tails [45].The properties of the 
cytoskeleton, including the identity of the assembled proteins, depend on many factors, 
including cell type, integrin type, and environmental cues, to name a few. These factors must 
be considered when measuring the cytoplasmic proteins that affect integrin clustering. It was 
not previously known that the role cytoplasmic proteins play in altering integrin clustering 
depends on the extracellular ligand density, and on the integrin’s ligand affinity, as measured 
using integrin mutants. Similar to other RNAi screens that have been performed [42,46], 
reduced expression levels of the target proteins have not been quantitatively measured for all 
targeted proteins. It is possible that some of the target cytoplasmic proteins affect integrin 
clustering, but only when their expression level is reduced below the amount produced in 
these studies. Additionally, some cytoplasmic proteins may alter integrin clustering only 
when their expression level is increased.  The combination of FRET and RNAi will 
contribute to a greater understanding of the proteins involved in receptor organization. 
 
ACKNOWLEDGMENTS 
This work was supported by the Roy J. Carver Charitable Trust (Muscatine IA), National 
Science Foundation (CHE-0845236) and Iowa State University Office of the Vice President 
for Research. The authors thank Roger Tsien (Howard Hughes Medical Institute, La Jolla, 
CA) for the original mCherry plasmid, Atsushi Miyawaki (Riken, Wako-city, Saitama, 
Japan) for the original Venus plasmid, Christopher Gonwa-Reeves, Neha Arora, Khushboo 
Hemnani and Keyna Eilor (Iowa State University) for their assistance with data processing. 
67 
 
REFERENCES 
1. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science (New York, NY 285 
(5430):1028-1032 
2. Ginsberg MH, Partridge A, Shattil SJ (2005) Integrin regulation. Current opinion in cell 
biology 17 (5):509-516 
3. Tanentzapf G, Brown NH (2006) An interaction between integrin and the talin FERM 
domain mediates integrin activation but not linkage to the cytoskeleton. Nat Cell Biol 8 
(6):601-606 
4. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, 
Bell JC, Dedhar S (1996) Regulation of cell adhesion and anchorage-dependent growth 
by a new beta 1-integrin-linked protein kinase. Nature 379 (6560):91-96 
5. Liu S, Thomas SM, Woodside DG, Rose DM, Kiosses WB, Pfaff M, Ginsberg MH (1999) 
Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses. 
Nature 402 (6762):676-681 
6. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW (2000) Ligand binding to integrins. The 
Journal of biological chemistry 275 ( 
29):21785-21788 
7. Selvin PR (2000) The renaissance of fluorescence resonance energy transfer. Nat 
StructBiol 7 (9):730-734 
8. Smith EA, Bunch TA, Brower DL (2007) General in vivo assay for the study of integrin 
cell membrane receptor microclustering. Anal Chem 79 (8):3142-3147 
9. Kim M, Carman CV, Yang W, Salas A, Springer TA (2004) The primacy of affinity over 
clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol 167 
(6):1241-1253 
10. Buensuceso C, de Virgilio M, Shattil SJ (2003) Detection of integrin alpha IIbbeta 3 
clustering in living cells. The Journal of biological chemistry 278 (17):15217-15224 
11. Dibya D, Sander S, Smith E (2009) Identifying cytoplasmic proteins that affect receptor 
clustering using fluorescence resonance energy transfer and RNA interference. Analytical 
and Bioanalytical Chemistry 
12. Helsten TL, Bunch TA, Kato H, Yamanouchi J, Choi SH, Jannuzi AL, Feral CC, 
Ginsberg MH, Brower DL, Shattil SJ (2008) Differences in regulation of Drosophila and 
vertebrate integrin affinity by talin. MolBiol Cell 19 (8):3589-3598 
13. Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, Hahn KM (2004) Vinculin 
modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J 
Cell Biol 165 (3):371-381 
14. Legate KR, Montañez E, Kudlacek O, Fässler R (2006) ILK, PINCH and parvin: the tIPP 
of integrin signalling. Nat Rev Mol Cell Biol 7 (1):20-31 
15. Prokopenko SN, Brumby A, O'Keefe L, Prior L, He Y, Saint R, Bellen HJ (1999) A 
putative exchange factor for Rho1 GTPase is required for initiation of cytokinesis in 
Drosophila. Genes Dev 13 (17):2301-2314 
16. Li R, Babu CR, Lear JD, Wand AJ, Bennett JS, DeGrado WF (2001) Oligomerization of 
the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. 
Proceedings of the National Academy of Sciences of the United States of America 98 
(22):12462-12467 
68 
 
17. Bunch TA, Grinblat Y, Goldstein LS (1988) Characterization and use of the Drosophila 
metallothionein promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res 
16 (3):1043-1061 
18. Bunch TA, Helsten TL, Kendall TL, Shirahatti N, Mahadevan D, Shattil SJ, Brower DL 
(2006) Amino acid changes in Drosophila alphaPS2betaPS integrins that affect ligand 
affinity. The Journal of biological chemistry 281 (8):5050-5057 
19. Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, Hemmings BA, 
Dixon JE (2000) Use of double-stranded RNA interference in Drosophila cell lines to 
dissect signal transduction pathways. Proceedings of the National Academy of Sciences 
of the United States of America 97 (12):6499-6503 
20. March JC, Bentley WE (2006) Engineering eukaryotic signal transduction with RNAi: 
enhancing Drosophila S2 cell growth and recombinant protein synthesis via silencing of 
TSC1. BiotechnolBioeng 95 (4):645-652 
21. FLIGHT. http://flightlicrorg/ 
22. PeptideAtlas. wwwmopunizhch/peptideatlas 
23. Graner MW, Bunch TA, Baumgartner S, Kerschen A, Brower DL (1998) Splice variants 
of the Drosophila PS2 integrins differentially interact with RGD-containing fragments of 
the extracellular proteins tiggrin, ten-m, and D-laminin 2. The Journal of biological 
chemistry 273 (29):18235-18241 
24. Zal T, Gascoigne NR (2004) Photobleaching-corrected FRET efficiency imaging of live 
cells. Biophys J 86 (6):3923-3939 
25. Gordon GW, Berry G, Liang XH, Levine B, Herman B (1998) Quantitative fluorescence 
resonance energy transfer measurements using fluorescence microscopy. Biophys J 74 
(5):2702-2713 
26. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) 
Improved monomeric red, orange and yellow fluorescent proteins derived from 
Discosoma sp. red fluorescent protein. Nat Biotechnol 22 (12):1567-1572 
27. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A (2002) A variant of 
yellow fluorescent protein with fast and efficient maturation for cell-biological 
applications. Nat Biotechnol 20 (1):87-90 
28. Bland JM, Altman DG (1996) The use of transformation when comparing two means. 
BMJ 312 (7039):1153 
29. Zar J (1999) Biostatistical Analysis. Prentice Hall, Upper Saddle River, NJ 
30. Luo BH, Springer TA (2006) Integrin structures and conformational signaling. Current 
opinion in cell biology 18 (5):579-586 
31. Calvete JJ (2004) Structures of integrin domains and concerted conformational changes 
in the bidirectional signaling mechanism of alphaIIbbeta3. Experimental biology and 
medicine (Maywood, NJ 229 (8):732-744 
32. Fogerty FJ, Fessler LI, Bunch TA, Yaron Y, Parker CG, Nelson RE, Brower DL, 
Gullberg D, Fessler JH (1994) Tiggrin, a novel Drosophila extracellular matrix protein 
that functions as a ligand for Drosophila alpha PS2 beta PS integrins. Development 120 
(7):1747-1758 
33. Jannuzi AL, Bunch TA, Brabant MC, Miller SW, Mukai L, Zavortink M, Brower DL 
(2002) Disruption of C-terminal cytoplasmic domain of betaPS integrin subunit has 
dominant negative properties in developing Drosophila. MolBiol Cell 13 (4):1352-1365 
69 
 
34. Jannuzi AL, Bunch TA, West RF, Brower DL (2004) Identification of integrin beta 
subunit mutations that alter heterodimer function in situ. MolBiol Cell 15 (8):3829-3840 
35. Armknecht S, Boutros M, Kiger A, Nybakken K, Mathey-Prevot B, Perrimon N (2005) 
High-throughput RNA interference screens in Drosophila tissue culture cells. Methods 
Enzymol 392:55-73 
36. Fessler JH, Fessler LI (1989) Drosophila extracellular matrix. Annu Rev Cell Biol 5:309-
339 
37. Bökel C, Brown NH (2002) Integrins in development: moving on, responding to, and 
sticking to the extracellular matrix. Dev Cell 3 (3):311-321 
38. Brower DL (2003) Platelets with wings: the maturation of Drosophila integrin biology. 
Current opinion in cell biology 15 (5):607-613 
39. FlyBase (http://flybase.bio.indiana.edu).  
40. Sander SA, N. Smith, E.A. (2012) Elucidating the role of select cytoplasmic proteins in 
altering diffusion of integrin receptors. Anal BioanalChem 
41. Waters JC (2009) Accuracy and precision in quantitative fluorescence microscopy. The 
Journal of cell biology 185 (7):1135-1148 
42. Kiger AA, Baum B, Jones S, Jones MR, Coulson A, Echeverri C, Perrimon N (2003) A 
functional genomic analysis of cell morphology using RNA interference. J Biol 2 (4):27 
43. Echeverri CJ, Perrimon N (2006) High-throughput RNAi screening in cultured cells: a 
user's guide. Nat Rev Genet 7 (5):373-384 
44. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, 
Ginsberg MH (1994) Integrin cytoplasmic domains mediate inside-out signal 
transduction. J Cell Biol 124 (6):1047-1059 
45. Delon I, Brown NH (2007) Integrins and the actin cytoskeleton. Current opinion in cell 
biology 19 (1):43-50 
46. Boutros M, Kiger AA, Armknecht S, Kerr K, Hild M, Koch B, Haas SA, Paro R, 
Perrimon N (2004) Genome-wide RNAi analysis of growth and viability in Drosophila 
cells. Science (New York, NY 303 (5659):832-835 
 
 
70 
 
Table 1.Measured expression ratios for integrins and FRET reporters. 
 Measurement 
(Roman numerals refer to measurements 
described in the text) 
Expression Ratio 
(All denominators are 1) 
 
1 Venus)(
)(
−αβ
αβ
ii
i
 1.4 ± 0.35 
 
2 Reporter FRET Venus;
Venus
)(
)(
αβ
αβ −
iv
iii
 3.3 ± 1.3 
 
3 Reporters FRETCherry  and Venus ;αβ
αβ
 2.3 ± 0.55 
 
4 Reporters FRETCherry  and Venus ;αβ
βαana
 1.4 ± 1.3 
 
5  Reporters FRETCherry  and Venus ;
409
αβ
αβ DV
 3.9 ± 3.6 
 
6  Controls FRETCherry  and Venus ;αβ
αβ
 1.3 ± 0.83 
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Table 2. Normalized FRET values for cell lines expressing FRET reporters or controls and 
the indicated integrins. Data is normalized and statistically compared to the value 
obtained for cells expressing wild-type integrins with FRET reporters.  
αβ; Reporters αanaβ; Reporters αβV409D; Reporters αβ; Controls 
1.0 
1.2 
(p=0.61) 
1.3 
(p=0.27) 
1.0 
(p=0. 88) 
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Table 3. Normalized FRET values for S2 cells expressing wild-type integrins and FRET 
reporters or wild-type integrins and FRET controls after the indicated RNAi treatment.  
 
αβ; Reporters     
RNA 1 Normalized2 Mean FRET P-value 
SD 1.2 0.46 
Dock 1.0 0.96 
ILK 2.6 0.0014 
FAK 1.3 0.34 
Rhea 0.80 0.55 
Pax 0.84 0.52 
Vin 0.63 0.12 
αβ; Controls     
SD 1.4 0.11 
Dock 1.5 0.06 
ILK 1.1 0.74 
FAK 1.0 0.46 
Rhea 0.59 0.40 
Pax 1.1 0.77 
Vin 1.1 0.71 
 
1. The abbreviations used in this table are listed in Figure 1. 
2. For ease in comparison, all values are normalized to cells expressing wild-type integrins 
and FRET reporters (αβ; Reporters) or FRET controls (αβ; Controls) with no RNAi 
treatment. 
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Table 4.Normalized FRET values for S2 cells expressing αβV409D mutant integrins and 
FRET reporters or αanaβ mutant integrins and FRET reporters after the indicated RNAi 
treatment. 
 
αanaβ; Reporters     
RNA1 Normalized Mean FRET2 P-value 
SD 2.2 0.0001 
Dock 0.68 0.27 
ILK 0.79 0.43 
FAK 0.84 0.0011 
Rhea 0.43 0.30 
Pax 1.9 0.0051 
Vin 0.83 0.51 
αβV409D; Reporters     
SD 0.82 0.43 
Dock 0.83 0.49 
ILK 0.24 0.019 
FAK 0.43 0.0045 
Rhea 0.63 0.54 
Pax 0.67 0.11 
Vin 0.40 0.0006 
1. The abbreviations used in this table are listed in Figure 1. 
2. For ease in comparison, all values are normalized to cells expressing αanaβ (αanaβ; 
Reporters) or αβV409D (αβV409D; Reporters) mutant integrins and FRET reporters with no 
RNAi treatment.  
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Figure 1.Schematic depicting FRET assay and proteins known to be involved in integrin 
signaling complexes. Cytoplasmic proteins targeted in this study to measure how they affect 
integrin clustering: Rhea, Vinculin (Vin), Integrin Linked Kinase (ILK),Paxillin (Pax), 
Dreadlock (Dock), Steamer Duck (SD) and Focal Adhesion Kinase (FAK). V: donor 
fluorescent protein (Venus); C: acceptor fluorescent protein (Cherry). (A) A baseline energy 
transfer value is measured in cells prior to receiving an RNAi treatment. (B) After removal of 
a target cytoplasmic protein (e.g. Paxillin), increased integrin clustering results in clustering 
of the FRET reporters, and an increase in energy transfer is measured. (C) After removal of a 
target cytoplasmic protein (e.g. Rhea), decreased integrin clustering results in less clustering 
of the FRET reporters, and a decrease in energy transfer is measured.This is a static picture 
of a dynamic system. 
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Figure 2.Relative mRNA expression as determined by real time polymerase chain reaction 
after RNAi treatment for either the indicated gene (white bar) or the Myospheroid gene (gray 
bar). 
 
a
 Relative indicates the ratio of mRNA in cells after RNAi treatment to mRNA in cells before 
RNAi treatment for the indicated gene, endogenous control gene gamma tubulin at 23C. All 
measurements were performed in duplicate.  
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Supplemental Information for Chapter 3 
Immunocytochemistry 
Expression levels of dreadlocks (Jack Dixon, University of Michigan) (), paxillin (Santa Cruz 
Biotechnology), vinculin (Santa Cruz Biotechnology) and akt1 (Cell Signaling Technology) 
were measured in αβ cells by immunocytochemistry with antibodies obtained from the 
referenced suppliers. Cells were spread on a ligand/BSA coated slide for 1 hour, and were 
then fixed with 4% paraformaldehyde in phosphate buffer for 10 minutes. The cells were 
thoroughly rinsed with phosphate buffer, and then incubated with primary antibody 
(Vinculin: 4 μg mL-1; Paxillin: 4 μg mL-1; dreadlocks:1:100 dilution; akt1: 1:175 dilution 
from supplied stock) diluted in M3 medium plus 2 mg mL-1 BSA for 2 hours at room 
temperature in a humid chamber. The cells were rinsed with M3 medium plus 2 mg mL-1 
BSA and then incubated with secondary antibody purchased from Invitrogen (dreadlocks: 
0.002 mg mL-1 goat anti-rabbit Alexa Fluor 647;akt1: 0.0027 mg mL-1 goat anti-rabbit 
labeled Alexa Fluor 647; vinculin and paxillin:0.002 mg mL-1 chicken anti-goat labeled 
Alexa Fluor 488) diluted in M3 medium plus 2mg mL-1BSA for 2 hours at room temperature 
in a humid chamber. To minimize background, the cells were washed thoroughly with 
phosphate buffer and imaged using a 60x, 0.95 numerical aperture objective with mercury 
lamp excitation. The following excitation and emission filters for Alexa Fluor 647 (645/20 
nm and 660/20 nm) and Alexa Flour 488 (470/50 nm and 545/75 nm) were used. The same 
exposure time (0.5second) was used to collect all images. To minimize measurement error 
the excitation intensity was set to ensure less than 5% photobleaching of the fluorophores 
occurred within 30 minutes (Waters2009). 
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Figure S1. Histograms showing the distribution of the natural log of the FRET intensities for 
A) αβ βCV, B) CD2CV, C) αanaβ βCV, D) αβV409D βCV cell lines at different tiggrin 
concentrations where white is 0 µg/mL, light gray is 0.05 µg/mL, and dark gray is 0.5 µg/mL 
tiggrin.  There are between 85-135 cells for each histogram. 
 
     
A B 
C D
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Figure S2.Quantitative immunocytochemistry measurements of protein expression. (A-J) 
Histograms showing the immunocytochemistry results for the total cellular expression before 
RNAi treatment (A, C, E, G) and after RNAi treatment (B, D, F, H) for akt1, dreadlocks, 
vinculin, and paxillin, respectively. The reported percentage value represents the change in 
the mean fluorescence value after RNAi treatment. An average of 150-300 cells was 
analyzed in three replicate measurements. Histograms showing the protein expression 
measurements for the total cellular expression before RNAi treatment (I) and after RNAi 
treatment (J) for actin 42A.The cells are expressing an actin 42A-GFP fusion protein. The 
reported percentage value represents the change in the mean fluorescence value after RNAi 
treatment. (I and J) Reproduced from reference Dibya, D., Sander, S., Smith, E. A. (2009) 
Identifying Cytoplasmic Proteins that Affect Receptor Clustering using Fluorescence 
Resonance Energy Transfer and RNA Interference, Analytical and Bioanalytical Chemistry 
395, 2303-2311. 
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 Figure S3. S2 cells containing wild
days after RNAi treatment using Rho1 dsRNA.  Cells that have successful
dsRNA have two nuclei as depicted by the arrows. (C) The percentage of S2 cells expressing 
wild-type integrins and FRET reporters that are multinucleate after RNAi treatment for 
Rho1. 
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Figure S4. Histograms of αβ βCV cells with the indicated RNAi treatment (A-H) control, 
vinculin, paxillin, rhea, FAK, ILK, dock steamer duck  The histograms show the distribution 
of the natural log of the FRET intensities at low and high tiggrin concentrations (light gray is 
0.05 µg/mL, and dark gray is 0.5 µg/mL tiggrin).  There are between 85-135 cells for each 
histogram.  
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Figure S5. Histograms of CD2CV cells at low and high tiggrin concentrations (light gray is 
0.05 µg/mL, and dark gray is 0.5 µg/mL tiggrin) with the corresponding RNAi treatments 
(A-H) control, vinculin, paxillin, rhea, FAK, ILK, dock, steamer duck. There are between 85-
135 cells for each histogram. 
 
 
 
 
 
B 
 
C 
 
D 
 
E 
 
F 
 
G 
 
H 
 
82 
 
Figure S6. Histograms of αanaβ βCV cells, at low and high tiggrin concentrations (light gray 
is 0.05 µg/mL, and dark gray is 0.5 µg/mL tiggrin) with the corresponding RNAi treatments 
(A-H)control, vinculin, paxillin, rhea, FAK, ILK, dock, steamer duck.  There are between 85-
135 cells for each histogram.  
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Figure S7.Histograms of αβV409D βCV cells, at low and high tiggrin concentrations (light 
gray is 0.05 µg/mL, and dark gray is 0.5 µg/mL tiggrin) with the corresponding RNAi 
treatments (A-H)control, vinculin, paxillin, rhea, FAK, ILK, dock, steamer duck.  There are 
between 85-135 cells for each histogram.  
 
 
 
 
 
A 
 
C 
 
D 
 
E 
 
F 
 
G 
 
H 
 
B 
 
84 
 
CHAPTER 4: THE BIOPHYSICAL ROLE OF CHOLESTEROL ON 
INTEGRIN DIFFUSION IN LIVE CELLS  
 Suzanne Sander and Emily A. Smith   
ABSTRACT 
Cholesterol is of fundamental importance to the fluidity of the membrane and can 
influence different cellular connections including signal generation and receptor diffusion. 
Cholesterol levels were reduced in S2 cells using methyl-β-cyclodextrin (mβCD), and 
restored using mβCD:cholesterol or mβCD:epicholesterol complexes. Cholesterol 
concentration from cell extracts was quantified using Amplex Red Cholesterol Assay.  
Diffusion values were calculated by fitting fluorescence recovery after photobleaching 
(FRAP) curves to a model for time-dependent diffusion with an immobile fraction. At native 
cholesterol concentrations, integrin mobility is 77% ± 2% with a time-dependent diffusion of 
8.4 ± 0.7 x 10-9 cm2/sec at 1 sec and 5.0±0.5 x 10-9 cm2/sec at 50 sec. At decreased 
cholesterol concentrations the mobile fraction decreases to 58% ± 0.02 with a faster time-
dependent diffusion coefficient of 18 ± 1 x 10-9 cm2/sec at 1 sec and 25 ± 5 x 10-9 cm2/sec at 
50 sec. Restoration of cholesterol to the cell membrane confirms that the change in integrin 
diffusion upon cholesterol extraction was cholesterol specific. In fact, integrin diffusion 
properties are restored to values measured at native cholesterol concentrations regardless of 
whether the restored sterol is cholesterol or its stereoisomer epicholesterol. After restoration 
of epicholesterol to the cell membrane, the mobile fraction is restored to 74% ± 3% and the 
time-dependent diffusion values slow to near the original values of 9 ± 1 x 10-9 cm2/sec at 1 
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sec and 3.1 ± 0.4 x 10-9 cm2/sec at 50 sec.  Alterations to lipid diffusion are minimal and not 
correlated to cholesterol concentration. 
 
INTRODUCTION 
Cholesterol is a sterol that plays a fundamental role in regulating cell membrane 
fluidity[1] and helps stabilize and strengthen the membrane. Due to its hydroxyl group and 
hydrophobic body, cholesterol orients itself in such a way to maximize hydrophobic and 
hydrophilic interactions.  The distribution of cholesterol in the membrane is proposed to be 
heterogeneous.  Research has indicated that cholesterol along with sphingomyelin may be 
necessary for the formation of lipid nanodomains [2-3], which have higher concentrations of 
certain membrane proteins and lipids and are more ordered. These domains are more rigid 
than the rest of the membrane and have been implicated in co-localizing proteins and lipids 
necessary for transmembrane signaling [4-5]. Specific details concerning size, composition, 
formation and function of lipid nanodomains remain uncertain. Additionally, the size and 
composition of lipid nanodomains can change in response to surrounding stimuli [6]. 
Analysis of influenza virus haemagglutinin with cholesterol suggests that the transmembrane 
domain is required for participation in lipid nanodomains [7]. 
Research has shown that lipid bilayers exist in several phases with increasing fluidity: 
gel, liquid-ordered, and liquid-disordered states [8]. As an integral component of cell 
membranes, this study helps define cholesterol’s function in regulating membrane receptor 
mobility and diffusion in the membrane. Due to the importance of cholesterol in the plasma 
membrane of cells, methods have been developed to manipulate cholesterol concentrations. 
The most common technique is through the use of cyclodextrins.  Their hydrophobic cavity 
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extracts cholesterol from cells. The exact mechanism has not been established and 
cholesterol may be removed from both nanodomains as well as from other areas of the 
membrane (i.e. the bulk).  Cyclodextrins alter the amount of cholesterol in both the plasma 
and intracellular membranes.   While there is the potential for other hydrophobic molecules 
to be extracted from the membranes, mβCD preferentially extracts cholesterol [9-10].  
Epicholesterol is an optical isomer of cholesterol that is rarely found in nature (Figure 1A).    
By replacing cholesterol with epicholesterol the specificity of  cholesterol’s function in 
altering diffusion in the cell can be isolated and described as either a biophysical or a 
biochemical process[11].  
One group of transmembrane proteins that is known to be involved in the transfer of 
information into and out of cells is integrins.  Integrins consist of an α and β subunit and span 
the membrane. Integrins have a small intracellular domain that interacts with cytoplasmic 
proteins and a large extracellular domain that interacts with ligand.  Since neither of the 
subunits have enzymatic activity, these interactions are needed for signal transduction. 
Integrins have been implicated in many basic cell functions including cell mobility, survival, 
and growth [12]. 
 This study utilizes methyl-β-cyclodextrin to alter the sterol concentration in 
Drosophila S2 cells transfected  to express αPS2CβPS integrin [13]. Fluorescence recovery 
after photobleaching (FRAP) measures the movement of fluorescent molecules into a region 
of the membrane that has been previously photobleached [14].  Comparison of the resulting 
diffusion parameters obtained from fitting the FRAP curves: mobile fraction, time exponent, 
and diffusion coefficients reveals information regarding the role cholesterol on integrins. 
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MATERIALS AND METHODS  
 Cell culture. Experiments utilized permanently transfected S2 cells cultured in 
Shields and Sang M3 medium (M3, Sigma) with 10% fetal calf serum (FCS) and antibiotics 
as previously published [15].  S2 cells expressed either wild-type αPS2CβPS integrins (αβ) 
or αPS2CβPS integrins with a Venus fluorescent protein (αβ-Venus) in the serine-rich loop 
[16-17]. The αβ cell line was used to quantify cellular and membrane cholesterol or measure 
lipid diffusion, while the αβ-Venus cell line was used to measure integrin diffusion.   
 Cholesterol depletion and restoration. To induce integrin expression, cells were 
heat shocked for 30 min at 36 °C and allowed to recover for 2 h at 22 °C.  Cells were 
centrifuged at 600xg and resuspended at a concentration of 3 x 106 cells/mL in either M3 
medium (control) or varying concentrations of mβCD solution (0.0625mM, 0.5mM, 2mM) 
and incubated for 30 min at 22 °C.  To remove the mβCD solution, cells were centrifuged at 
600xg and resuspended in an equal volume of M3 and incubated for an additional 30 min. 
For cholesterol restoration, preparation of cholesterol or epicholesterol-loaded 
cyclodextrin (mβCD-chol and mβCD-epichol) was prepared as previously published [13]. 
Briefly, 800 µg of cholesterol/epicholesterol were dried under a stream of nitrogen.  The 
samples were then resuspended in either 1 or 2.5 mM mβCD, vortexed, sonicated, and 
incubated with shaking overnight at 37 °C. Instead of the final incubation in M3 media, the 
cells were resuspended in M3 medium containing mβCD-chol or mβCD-epichol complex for 
30 min at 22°C, after which time the cells were centrifuged and resuspended in M3 medium. 
 Extraction of total cellular lipids. After heat shock and incubation, the cellular 
lipids were extracted using the Bligh-Dyer method [18].  Briefly 3.0 mL 
methanol/chloroform (2:1 v/v) was added to 106 cells.  The sample was vortexed for 15 min 
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and 1.0 mL of 1.0 M NaCl was added and vortexed for 1 min.  The solution was allowed to 
sit for 12 h.  The chloroform phase was collected and filtered with Whatman filter paper No. 
1 and then evaporated under nitrogen.  The cellular lipids were resuspended in phosphate 
buffer from the Amplex Red Cholesterol Assay kit (0.1M potassium phosphate, pH 7.4, 
50mMNaCl, 5 mM cholic acid, and 0.1% Triton X-100) (Life Technologies A12216). 
 Extraction of membrane lipids. After heat shock and incubation, lipid extraction 
was performed as previously described [19-20], with the following changes: Plated cells 
were allowed to spread for 1 h at 22 °C.  The membrane lipid was extracted with 5 mL 
methanol/chloroform (2:1 v/v) with continuous rocking for 1 h. Two mL of 1.0 M NaCl was 
added to the solution and vortexed for 1 min.  Filtration and resuspension was the same as 
that for that of cellular lipids. 
 Cholesterol quantification. Cholesterol levels were quantified using an Amplex Red 
cholesterol assay (Life Technologies, Carlsbad, CA) without cholesterol esterase [21] via a 
Synergy HT fluorescence microplate reader (BioTek Instruments) with an 530/25 nm  
excitation filter and a 590/35 nm emission filter. Values were background subtracted.  A 
calibration curve was constructed from five cholesterol standards (measured in triplicate). 
Since samples showed heteroscedasticity, the standards used a weighted linear fit. [20,22]. 
 Fluorescence recovery after photobleaching and data analysis. After cholesterol 
depletion or restoration (see above), cells were spread on 0.5 µg mL-1tiggrin coated slides at a 
concentration of 3E5 cells/mL for 1 hr and then rinsed with BES Tyrodes buffer as 
previously described [23]. For lipid diffusion measurements, 12 µMcarbocyanine dye DiD 
(Invitrogen, 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarboycyanine perchlorate) was 
added to the treated cells before plating on the slide. 
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Fluorescence images were collected on a Princeton Instruments PhotonMax 512 CCD 
using an Eclipse TE2000U microscope (Nikon), as previously described [24].  The camera 
gain for the αβ-Venus cell line was set to 3900. Due to the slower recovery time, integrin 
measurements were collected for 72 seconds, as compared to lipid measurements which were 
collected for 20 seconds.    
Fluorescence images were analyzed as previously described [24] by fitting them to 
three models based on Eq. 1 [25] with an in-house-developed Igor Pro macro (version 4.0). 
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F0 is the initial fluorescence intensity after photobleaching; Fin is the fluorescence intensity at 
an infinite recovery time; τ is the time for 50% of the fluorescence to recovery, and α is the 
time exponent providing a measure of how much diffusion is constrained. The most 
appropriate model set was determined by comparing the reduced chi2 values obtained for 
each model. The best fit model generates a reduced chi2 value of 1. Values obtained from the 
fit of the fluorescence recovery curve were used to calculate the diffusion coefficient, D(t) 
(Eq. 2).  
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where ω is the radius of the focused Gaussian laser beam and β is the photobleach depth [26].  
All diffusion parameters are listed in supplementary information Table S1 and S2. Diffusion 
parameters for the best-fit model of integrins and lipids are listed in Tables 2 and 3. Error 
bars on all reported FRAP fit parameters represent uncertainty at the 95% confidence level. 
Most of the curves were best fit to the time-dependent diffusion model.  The one exception 
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was that of the lipid control where Brownian diffusion with an immobile fraction is the best 
fit showing that the lateral diffusion of lipids is not time dependent in untreated cells.   
 
RESULTS AND DISCUSSION 
The goal of this study was to investigate the mechanism for cholesterol's modulation 
of integrin diffusion. Cholesterol may have either a chemical and/or physical role in altering 
integrin diffusion. Research has shown different roles of cholesterol as a modulator of 
receptors by reducing and restoring cholesterol in mammalian cells and monitoring changes 
in specific receptors. Research showed that the cholecystokinin receptor diffusion correlated 
with changes in membrane fluidity, while the affinity state for oxytocin receptor had a 
specific cholesterol requirement suggesting that this receptor is regulated by specific 
cholesterol-protein interactions [27]. If specific interactions between the cholesterol hydroxyl 
group and integrins alter integrin diffusion, than a change in cholesterol structure will disrupt 
these interactions and alter integrin diffusion.  If, however, cholesterol plays a biophysical 
role in integrin diffusion, then replacing cholesterol with its stereoisomer epicholesterol will 
not result in a change in integrin's diffusion properties.  
FRAP measurements (Figure 1C) to determine the diffusion properties of integrins in 
the cell membrane where cholesterol levels have been reduced and subsequently restored 
with cholesterol or its stereoisomer epicholesterol will reveal the role cholesterol plays in 
integrin diffusion. 
 Cholesterol depletion, restoration and quantification. Cholesterol was extracted 
from cells using different concentrations of mβCD and both total cellular and membrane 
cholesterol were quantified. Membrane cholesterol is most relevant to integrin diffusion in 
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the cell membrane, however, total cellular cholesterol concentration helps establish the 
effectiveness of the treatments and could reveal information about mβCD‘s mechanism for 
extracting cholesterol from the membrane. With increasing concentrations of mβCD, total 
cellular concentration is decreased by 30, 40 or 55% (Table 1).  The percent decrease in 
membrane cholesterol is lower than the measured decrease for total cellular cholesterol. 
Using 0.0625 mMmβCD there is no significant change in the membrane cholesterol 
concentration. However, higher mβCD concentrations reduce the membrane cholesterol 
concentration by 10 or 20% (Table 1).  Cholesterol restoration in cells using 2.5 mM mβCD-
chol effectively reverses the cholesterol depletion and actually increases the total cholesterol 
concentration by 45% as compared to native cholesterol concentrations.   
Integrin and lipid diffusion at native cholesterol concentration. The mobile 
fraction for cells containing normal cholesterol levels is 77 ± 2%, meaning that about a 
quarter of the integrins are immobile on the timescale of the experiment. The immobile 
fraction could be attributed to integrin interaction with other components of the cell or its 
surroundings [24] The integrin diffusion value is 8.4 ± 0.7 x 10-9 cm2/s at short analysis times 
and 5.0 ± 0.5 x 10-9 cm2/s, indicating that diffusion slows which is in part due to ligand 
integrin interactions [24]. 
There are no significant changes in either the integrin mobile fraction or the diffusion 
time constant (hereafter, alpha) after cholesterol is depleted using 0.0625 mM mβCD.  This is 
not surprising since total cellular cholesterol concentration decreased, but membrane 
cholesterol did not change at this mβCD concentration.  At higher mβCD concentrations 
when 10 to 20% of the membrane cholesterol is extracted, the integrin mobile fraction 
decreased by 42% or 25% and alpha increased by 13% or 26%, respectively. Interestingly, 
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the magnitude change in the mobile fraction and alpha are not correlated.  Reduced 
membrane cholesterol results in less mobile integrin, but the fraction that remains mobile has 
a faster, more Brownian-like diffusion. 
Integrin and lipid diffusion at reduced cholesterol concentration. The lateral 
diffusion of αPS2CβPS integrins was measured in Drosophila cells after cholesterol 
reduction using various concentrations of mβCD (Table 1).  The average integrin FRAP 
curves at a native cholesterol concentration from ten replicate measurements (Figure 2) were 
fit and was found to be best-fit by a time-dependent diffusion with an immobile fraction 
model. In order to distinguish the diffusion coefficient at different times in the subsequent 
discussion, short analysis times refer to diffusion at 1 s while long analysis times refer to 
diffusion at 50 s. Integrin parameters for the mβCD treatments (Table 2) show that decreased 
levels of cholesterol decrease the mobile fraction and increase the integrin diffusion at both 
short and long analysis times.   
Integrin and lipid diffusion at restored cholesterol or epicholesterol 
concentration. Qualitative differences in integrin diffusion at depleted and restored 
cholesterol concentrations are evident from the FRAP curves (Figure 2). Total cholesterol 
was restored to a higher concentration than was initially present in the cells. The resulting 
integrin diffusion in cells containing restored cholesterol returned to their original values at 
short analysis times, while at longer analysis times, diffusion was slower than measured at 
native cholesterol concentrations (Table 2). Higher than native cholesterol concentration in 
the membrane results in a greater number of mobile integrins, however, the movement of the 
mobile integrin population is slower. Comparable results were observed when similar 
amounts of epicholesterol were reintroduced into the cells. The combined data of restoring 
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cholesterol/epicholesterol to the cell membrane indicate that cholesterol plays a biophysical 
role in influencing integrin diffusion and mobility within the membrane (Figure 3). 
Unexpectedly, lipid diffusion parameters did not significantly change when 
cholesterol was reduced, restored, or replaced with epicholesterol (Table 3). One possible 
explanation for this observation is that the lipid diffusion parameters represent only a subset 
of the lipid in the cell membrane, for example the bulk membrane or nanodomain regions.  It 
is also possible that the method to measure lipid diffusion lacks sensitivity to measure small 
changes in lipid diffusion with statistical confidence.  Further studies are underway to 
explore the unexpected lack of change in lipid diffusion. 
 
CONCLUSIONS 
Cholesterol plays a role in integrin diffusion within the cell membrane.  By reducing 
the cholesterol concentrations using mβCD, integrin diffusion values at 1 second (8.4 ± 0.7 
x10-9cm2/sec) were increased by a factor of 2, integrin diffusion values at 50 seconds were 
increased by a factor of 5 and there is a decrease in the mobile fraction as depicted in Figure 
3. At 50 seconds the diffusion was 5 times faster  changing 5.0 ± 0.5  to a rate of 25 ± 5 
However, after epicholesterol was restored to the membrane via a mβCD-epichol complex, 
diffusion parameters were restored to 9 ± 1 x10-9cm2/sec at 1 second which are close to the 
native diffusion. This indicates that the integrin cholesterol interactions are not due to the 
chemical position of cholesterol’s hydroxyl group, but instead cholesterol plays a biophysical 
role in integrin diffusion.  
 
 
94 
 
ACKNOWLEDGEMENTS 
Support for this work was provided by the National Science Foundation (CHE-0845236). 
The authors thank Atsushi Miyawaki (Riken, Wako City, Saitama, Japan) for the original 
Venus plasmid. 
 
REFERENCES 
1. Oldfield E, Chapman D (1972) Dynamics of lipids in membranes: Heterogeneity and the 
role of cholesterol. FEBS letters 23 (3):285-297 
2. Brown DA, London E (2000) Structure and function of sphingolipid- and cholesterol-rich 
membrane rafts. The Journal of biological chemistry 275 (23):17221-17224 
3. Pankov R, Markovska T, Hazarosova R, Antonov P, Ivanova L, Momchilova A (2005) 
Cholesterol distribution in plasma membranes of beta1 integrin-expressing and beta1 
integrin-deficient fibroblasts. Archives of biochemistry and biophysics 442 (2):160-168 
4. Leitinger B, Hogg N (2002) The involvement of lipid rafts in the regulation of integrin 
function. Journal of cell science 115 (Pt 5):963-972 
5. Green JM, Zhelesnyak A, Chung J, Lindberg FP, Sarfati M, Frazier WA, Brown EJ (1999) 
Role of cholesterol in formation and function of a signaling complex involving 
alphavbeta3, integrin-associated protein (CD47), and heterotrimeric G proteins. The 
Journal of cell biology 146 (3):673-682 
6. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nature reviews 1 (1):31-
39 
7. Scheiffele P, Roth MG, Simons K (1997) Interaction of influenza virus haemagglutinin 
with sphingolipid-cholesterol membrane domains via its transmembrane domain. The 
EMBO journal 16 (18):5501-5508 
8. Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annual 
review of cell and developmental biology 14:111-136 
9. Kilsdonk EP, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ, Phillips MC, Rothblat 
GH (1995) Cellular cholesterol efflux mediated by cyclodextrins. The Journal of 
biological chemistry 270 (29):17250-17256 
10. Zidovetzki R, Levitan I (2007) Use of cyclodextrins to manipulate plasma membrane 
cholesterol content: evidence, misconceptions and control strategies. Biochimica et 
biophysica acta 1768 (6):1311-1324 
11. Ge S, White JG, Haynes CL (2010) Critical role of membrane cholesterol in exocytosis 
revealed by single platelet study. ACS chemical biology 5 (9):819-828 
12. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science (New York, NY 285 
(5430):1028-1032 
13. Christian AE, Haynes MP, Phillips MC, Rothblat GH (1997) Use of cyclodextrins for 
manipulating cellular cholesterol content. Journal of lipid research 38 (11):2264-2272 
95 
 
14. Axelrod D, Koppel DE, Schlessinger J, Elson E, Webb WW (1976) Mobility 
measurement by analysis of fluorescence photobleaching recovery kinetics. Biophysical 
journal 16 (9):1055-1069 
15. Bunch TA, Grinblat Y, Goldstein LS (1988) Characterization and use of the Drosophila 
metallothionein promoter in cultured Drosophila melanogaster cells. Nucleic acids 
research 16 (3):1043-1061 
16. Bunch TA, Salatino R, Engelsgjerd MC, Mukai L, West RF, Brower DL (1992) 
Characterization of mutant alleles of myospheroid, the gene encoding the beta subunit of 
the Drosophila PS integrins. Genetics 132 (2):519-528 
17. Bunch TA, Helsten TL, Kendall TL, Shirahatti N, Mahadevan D, Shattil SJ, Brower DL 
(2006) Amino acid changes in Drosophila alphaPS2betaPS integrins that affect ligand 
affinity. The Journal of biological chemistry 281 (8):5050-5057 
18. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. 
Canadian journal of biochemistry and physiology 37 (8):911-917 
19. Bezrukov L, Blank PS, Polozov IV, Zimmerberg J (2009) An adhesion-based method for 
plasma membrane isolation: evaluating cholesterol extraction from cells and their 
membranes. Analytical biochemistry 394 (2):171-176 
20. Dibya D, Arora N, Smith EA (2010) Noninvasive measurements of integrin 
microclustering under altered membrane cholesterol levels. Biophysical journal 99 
(3):853-861 
21. Amundson DM, Zhou M (1999) Fluorometric method for the enzymatic determination of 
cholesterol. Journal of biochemical and biophysical methods 38 (1):43-52 
22. Almeida AM, Castel-Branco MM, Falcao AC (2002) Linear regression for calibration 
lines revisited: weighting schemes for bioanalytical methods. Journal of chromatography 
774 (2):215-222 
23. Dibya D, Sander S, Smith EA (2009) Identifying cytoplasmic proteins that affect receptor 
clustering using fluorescence resonance energy transfer and RNA interference. Analytical 
and bioanalytical chemistry 395 (7):2303-2311 
24. Sander SA, N. Smith, E.A. (2012) Elucidating the role of select cytoplasmic proteins in 
altering diffusion of integrin receptors. Analytical and bioanalytical chemistry 
25. Feder TJ, Brust-Mascher I, Slattery JP, Baird B, Webb WW (1996) Constrained diffusion 
or immobile fraction on cell surfaces: a new interpretation. Biophysical journal 70 
(6):2767-2773 
26. Yguerabide J, Schmidt JA, Yguerabide EE (1982) Lateral mobility in membranes as 
detected by fluorescence recovery after photobleaching. Biophysical journal 40 (1):69-75 
27. Gimpl G, Burger K, Fahrenholz F (1997) Cholesterol as modulator of receptor function. 
Biochemistry 36 (36):10959-10974 
  
96 
 
Table 1.Total cellular or membrane cholesterol concentration after the listed depletion or 
restoration treatment. 
 Cholesterol Concentration 
(femtamoles/cell) 
Cholesterol Depleted 
 Total Membrane 
0 mM mβCD 13 ± 2 3  ± 1 
0.0625 mM mβCD 9 ± 1 3.4 ± 0.4 
0.5 mM mβCD 8 ± 3 2.7 ± 0.7 
2 mM mβCD 6 ± 2 2 ± 1 
Cholesterol Depleted/Cholesterol Restored 
2mM mβCD + 
2.5 mM mβCD-chol 
19 ± 2 1.4 ± 0.4 
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Table 2. Integrin diffusion parameters as determined from the best-fit model of the FRAP 
curves for the αβ-Venus cell line before and after treatment with mβCD solutions. 
 
 
  
Treatments 
 
  
Mobile 
Fraction 
Time 
Exponent 
(α) 
Diffusion 
Coefficient 
at 1 s (x10-9 
cm2/s) 
Diffusion 
Coefficient 
at 50 s (x10-
9
 cm2/s) 
0mM mβCD 
 
0.77 ± 0.02 0.87 ± 0.04 8.4 ± 0.7 5.0 ± 0.5 
0.0625mM mβCD 
 
0.75 ± 0.02 0.85 ± 0.04 10.2 ± 0.7 5.6 ± 0.5 
0.5 mM mβCD 
 
0.45 ± 0.03 0.98 ± 0.11 14 ± 2 13 ± 5 
2mM mβCD 
 
0.58 ± 0.02 1.1 ± 0.06 18 ± 1 25 ± 5 
2mM mβCD 
2.5 mM mβCD-chol 
0.90 ± 0.05 0.71 ± 0.07 8 ± 1 2.6 ± 0.4 
2mM mβCD 
1.0 mM mβCD-epichol 
0.89 ± 0.01 0.84 ± 0.01 9.5 ± 0.3 5.0 ± 0.2 
2mM mβCD 
2.5 mM mβCD-epichol 
0.74 ± 0.03 0.72 ± 0.06 9 ± 1 3.1 ± 0.4 
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Table 3. Lipid diffusion parameters as determined from the best-fit model of the FRAP 
curves for the αβ cell line before and after treatment with mβCD solutions. 
 
Treatments Mobile 
Fraction 
Time 
Exponent 
(α) 
Diffusion 
Coefficient at 
1 s (x 10-9 
cm2/s) 
Diffusion 
Coefficient 
at 50 s (x 10-
9
 cm2/s) 
0mM mβCD 
 
0.87 ± 0.04  15 ± 2a  
0.0625mM mβCD 
 
0.83 ± 0.02 0.89 ± 0.05 20 ± 1 13 ± 2 
0.5mM mβCD 
 
0.88 ± 0.02 0.94 ± 0.05 17 ± 1 13 ± 2 
2mM mβCD 
 
0.94 ± 0.02 0.94 ±0.04 21.9 ± 0.8 18 ± 2 
2mM mβCD + 
2.5 mM mβCD-chol 
0.87 ±0.02 0.89 ± 0.04 19.5 ± 0.9 13 ± 2 
2mM mβCD + 
1.0 mM mβCD-
epichol 
0.91 ± 0.02 0.92 ± 0.04 20 ± 1 15 ± 2 
2mM mβCD + 
2.5 mM mβCD-
epichol 
0.87 ± 0.02 0.91 ± 0.04 21.4 ± 0.9 15 ± 2 
aData fit best to Brownian diffusion (α=1); diffusion coefficient will be the same values at all 
analysis times 
 
 
 
 
 
 
 
  
 Figure 1.(A) Structure of cholesterol and its stereoisomer (B) epicholesterol. The black 
arrow denotes the difference in position of the hydroxyl group (C) Images of a spread cell 
after epicholesterol levels were restored 
show the photobleached spot over time as well as a reference image prior to photobleaching.  
At longer time periods more fluorescent molecules have diffused into the photobleac
area. Ninety-nine images were taken at 0.77 sec intervals.
 
 
 
 
to the cell using 2.5mM mβCD-epichol.  Images 
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Figure 2.Average fluorescence recovery after photobleaching (FRAP) curves from 10 
replicate measurements (circles) of S2 cells expressing αPS2CβPS-Venus integrins (blue) at 
native cholesterol concentration;(black) reduced cholesterol concentration;(green) restored 
cholesterol concentration;(red) restored epicholesterol concentration.  The data are fit (solid 
lines following the same color scheme previously described) to a model for time-dependent 
diffusion with an immobile fraction. Curves have been normalized to the pre-photobleach 
intensity. 
 
  
  
Figure 3.Schematic showing how the presence of cholesterol or epicholesterol in the plasma 
membrane affects integrin diffusion.  Cholesterol intercalates in the lipid bilayer and 
influences membrane structure and fluidity.  Altered integrin diffusion is due to a biophysical 
role for cholesterol, and is not a result of a biochemical mechanism. Integrin diffusion 
properties are defined using a time
 
 
 
 
 
-dependent diffusion model with an immobile fraction.
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Supplemental Information for Chapter 4 
 
Table S1.Integrindiffusion parameters obtained by fitting FRAP curves to constrained (time 
dependent) diffusion, Brownian diffusion and time-dependent diffusion with an immobile 
fraction models for a cell line expressing αPS2CβPS-Venus integrins before (control) and 
after the indicated cholesterol depletion or restoration. The fit parameters from the best-fit 
model, either time dependent diffusion with an immobile fraction or Brownian diffusion, are 
shown in Table 2 of the manuscript. All cells are spread on a ligand coated microscope slide.  
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 
α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
Mobile 
fraction 
Diffusion 
Coefficient 
(x10-9cm2/s) 
Mobile 
Fraction α 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
0  mM mβCD 0.509 ± 
0.005 10.3 ± 0.2 1.52±0.02 
0.7± 
0.1 6.6 ± 0.8 
0.77 ± 
0.02 
0.87 ± 
0.04 
8.4 ± 0.7 5.0 ± 0.5 
0.0625  mM 
mβCD 
0.471 ± 
0.008 11.8 ± 0.4 1.49 ± 0.04 
0.7 ± 
0.1 8 ± 1 
0.75 ± 
0.02 
0.85 ± 
0.04 
10.2 ± 0.7 5.6 ± 0.5 
0.5 mM 
mβCD 
0.24 ± 
0.02 10.4 ± 0.9 0.54 ± 0.03 
0.4 ± 
0.1 14± 3 
0.45 ± 
0.03 
0.98 ± 
0.11 
14 ± 2 13 ± 5 
2  mM mβCD 0.263 ± 
0.008 16.6 ± 0.6 0.93 ±0.03  
0.6 ± 
0.1 19±2 
0.58 ± 
0.02 
1.1 ± 
0.06 
18 ± 1 25 ± 5 
2  mM mβCD 
2.5 mM 
mβCD-chol 
0.59 ± 
0.02 8.6 ± 0.7 1.7 ±0.1  
0.8 ± 
0.2 5.0 ±0.7 
0.90 ± 
0.05 
0.71 ± 
0.07 
8 ± 1 2.6 ± 0.4 
2  mM mβCD 
1.0 mM 
mβCD-epichol 
0.628 ± 
0.004 11.2 ± 0.2 2.63 ± 0.03 
0.85± 
0.09 3.6 ± 0.8 
0.89 ± 
0.01 
0.84 ± 
0.01 
9.5 ± 0.3 5.0 ± 0.2 
2  mM mβCD 
2.5 mM 
mβCD-epichol 
0.46 ± 
0.01 9.1 ± 0.5 1.10 ± 0.04  
0.7± 
0.1 5.8 ±0.8 
0.74 ± 
0.03 
0.72 ± 
0.06 
9 ± 1 3.1 ± 0.4 
a Diffusion parameters were obtained from fitting the average FRAP curve of replicate 
measurements with the standard deviation representing the uncertainty at the 95% confidence 
interval of the corresponding coefficients obtained in the fits. 
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Table S2.Lipiddiffusion parameters obtained by fitting FRAP curves to constrained (time 
dependent) diffusion, Brownian diffusion and time-dependent diffusion with an immobile 
fraction models for a cell line expressing αPS2CβPS integrins before (control) and after the 
indicated cholesterol depletion or restoration. The fit parameters from the best-fit model 
either Brownian diffusion or time dependent diffusion with an immobile fraction, are shown 
in Table 3 of the manuscript. All cells are spread on a ligand coated microscope slide. 
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 
α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
Mobile 
fraction 
Diffusion 
Coefficient 
(x10-9cm2/s) 
Mobile 
Fraction α 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-9cm2/s) 
0  mM mβCD 0.75 ± 
0.02 13.9 ± 0.7 5.2 ± 0.4 
0.86 ± 
0.02 15 ± 2 
0.87± 
0.04 
0.96 ± 
0.08 
15 ± 2 14 ± 4 
0.0625  mM 
mβCD 
0.64 ± 
0.01 16.3 ± 0.5 3.9 ± 0.2 
0.80 ± 
0.01 20 ± 3 
0.83 ± 
0.02 
0.89 ± 
0.05 
20 ± 1 13 ± 2 
0.5 mM mβCD 0.74 ± 
0.01 14.8 ± 0.4 5.3 ± 0.3 
0.86 ± 
0.01 17 ± 2 
0.88 ± 
0.02 
0.94 ± 
0.05 
17 ± 1 13 ± 2 
2  mM mβCD 0.81 ± 
0.01 20.7 ± 0.5 10.0 ± 0.5 
0.92 ± 
0.01 22 ± 3 
0.94 ± 
0.02 
0.94 
±0.04 
21.9 ± 0.8 18 ± 2 
2  mM mβCD 
2.5 mM mβCD-
chol 
0.68 ± 
0.02 16.8 ± 0.6 4.7 ± 0.3 
0.83 ± 
0.01 20 ± 2 
0.87 
±0.02 
0.89 ± 
0.04 
19.5 ± 0.9 13 ± 2 
2  mM mβCD 
1.0 mM mβCD-
epichol 
0.75 ± 
0.01 18.3 ± 0.5 6.9 ± 0.3 
0.88 ± 
0.01 20 ± 3 
0.91 ± 
0.02 
0.92 ± 
0.04 
20 ± 1 15 ± 2 
2  mM mβCD 
2.5 mM mβCD-
epichol 
0.689 ± 
0.01 18.3 ± 0.4 5.3 ± 0.2 
0.84 ± 
0.01 22 ± 3 
0.87 ± 
0.02 
0.91 ± 
0.04 
21.4 ± 0.9 15 ± 2 
a  Diffusion parameters were obtained from fitting the average FRAP curve of replicate 
measurements with the standard deviation representing the uncertainty at the 95% confidence 
interval of the corresponding coefficients obtained in the fits. 
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CHAPTER 5: GENERAL CONCLUSIONS AND FUTURE PROSPECTS 
General Conclusions 
 Due to the sensitivity, selectivity, and availability of extrinsic fluorescence sensors, 
fluorescence has become a prevalent method to study biological systems. Elucidating the 
molecular mechanism of integrin receptors in the membrane of live cells provides critical 
insight into a class of membrane proteins involved in basic cellular function, and provides 
clues about aberrant function that leads to diseases states. The work presented in this thesis 
uses fluorescence techniques, FRET and FRAP, in combination with RNAi, cholesterol 
sequestration, and varying ligand concentrations to compare how changes in cytoplasmic 
proteins, membrane cholesterol, and extracellular matrix concentrations affect integrin 
diffusion and clustering properties.  The techniques discussed can be applied to the study of 
other membrane receptors. 
 The techniques in chapter two combine FRAP with different ligand concentrations to 
show how extracellular matrix interactions are responsible for 25% of the integrin immobile 
fraction while at the same time reduce diffusion constraints.  Additionally, by combining 
FRAP with RNAi it was observed that interaction with different cytoplasmic proteins either 
increases or decreases integrins’ diffusion constraints, thereby affecting the movement of 
integrins in response to stimuli. 
 Chapter 3 combines FRET with RNAi revealing that out of the seven cytoplasmic 
proteins studied only ILK affected integrin clustering in the presence of high ligand densities.  
Mutant integrins, αanaβ and αβV409D, were also studied and different changes in clustering 
were observed as compared to the wild-type integrin.  Reduced expression of paxillin and 
steamer duck caused an increase in energy transfer in the αanaβ mutant integrin. Reduced 
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expression of ILK in the αβV409D mutation shows the opposite trend as the wild-type, 
which may be related to integrin-ligand affinity.   
 Chapter 4 combines FRAP with cholesterol sequestration to show that reduced 
cholesterol concentration increases integrin diffusion, while decreasing the mobile fraction.  
Diffusion parameters were restored to near native speeds of 8.4 ± 0.7 x 10-9 cm2/sec upon 
restoring membrane sterol levels using epicholesterol, a stereoisomer of cholesterol, 
indicating cholesterol plays a biophysical role in integrin diffusion. 
 
Future Directions 
 The FRET technique used to measure clustering in cells can be further developed in 
different directions, including observing how other membrane proteins, such as receptor 
tyrosine kinase (RTK), synaptobrevin, and tetraspanins affect integrin clustering.  
 While FRAP provides important ensemble diffusion information on integrins and 
their interactions with their surroundings, single particle tracking data will reveal the paths of 
individual integrins. This will provide additional information to help elucidate the molecular 
mechanisms of integrins.   
Integrin-ligand binding interactions can be further described by monitoring the 
interactions of fluorescently labeled TWOW-1, a ligand mimetic, with integrins.  Single 
molecule binding can be measured on the different integrin mutants under total internal 
reflection. Kinetic and thermodynamic effects on equilibrium binding parameters and 
diffusion coefficients will be identified.  
Appropriately designed FRET reporters can be developed to monitor the clustering of 
other membrane receptors such as glycoproteins or expanded to membrane receptors in 
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different cell systems i.e. mammalian. There are 24 known vertebrate integrins, whose 
function may vary depending upon cell type.  Conflicting research on how αvβ3 integrin 
affects angiogenesis has been reported [1]. Application of FRET to mammalian cells can help 
elucidate the mechanism and clarify discrepancies that may exist in the data.  Additionally, if 
similar integrin properties are observed in different cell lines, conservation of molecular 
function will be recognized. The combined understanding of how intracellular, extracellular, 
and membrane interactions affect the αvβ3integrin network may enhance the current anti-
angiogenic therapies based the function of this integrin. 
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APPENDIX 1: IDENTIFYING CYTOPLASMIC PROTEINS THAT 
AFFECT RECEPTOR CLUSTERING USING FLUORESCENCE 
RESONANCE ENERGY TRANSFER AND RNA INTERFERENCE 
 
A paper published in Analytical and Bioanalytical Chemistry 2009, 395 (7), 2303-2311* 
 
Deepak Dibya, Suzanne Sander and Emily A. Smith 
 
ABSTRACT 
 Unraveling the complex, dynamic organization of the cell membrane can provide 
vital information about many aspects of cellular functions. Reported herein is a method for 
identifying cytoplasmic proteins that affect cell membrane protein organization. RNA 
interference (RNAi) is used to reduce the expression of select cytoplasmic proteins and a 
fluorescence resonance energy transfer (FRET) assay is used to measure changes in receptor 
microclustering. The advantage of this assay is that it does not require attaching fluorescent 
tags to the receptor. A change in energy transfer after reducing the expression of a 
cytoplasmic protein provides information about the protein’s role in altering receptor 
organization. As a demonstration of the method, cytoplasmic proteins involved in integrin 
microclustering have been identified. The cytoplasmic proteins targeted in this study include: 
dreadlock, integrin-linked kinase, paxillin, steamer duck, vinculin, rhea, focal adhesion 
kinase, and actin 42A. 
*Reprinted with permission from The Journal of Analytical and Bioanalytical Chemistry  
Copyright © Springer-Verlag 2009  
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Reducing the expression of vinculin, paxillin, rhea, and focal adhesion kinase increased 
integrin microclustering, as measured by an increase in energy transfer in cells expressing 
αPS2CβPS integrins. No change in integrin microclustering was measured in a control cell 
line. Integrin mutants exhibited different microclustering properties compared to the wild-
type integrins after reducing the expression of the listed cytoplasmic proteins. The results 
demonstrate the utility of this assay format, and provide insight into the function of 
cytoplasmic proteins in integrin microclustering. 
 
INTRODUCTION 
 A dynamic flow of information between the extracellular and intracellular 
environments of a cell is required for survival, growth, proliferation, differentiation, and 
other basic functions (1). The primary signal transducers are receptor cell membrane 
proteins. Receptors transmit information through three primary mechanisms: (a) binding 
extracellular ligands; (b) engaging a cascading network of intracellular signaling partners; 
and (c) clustering within the membrane. Several analytical techniques, such as co-
immunoprecipitation, surface plasmon resonance, affinity chromatography, and two-hybrid 
systems, are used to measure the interactions of receptors with their intracellular and 
extracellular signaling partners (2). 
 Observing nanoscale receptor organization in live cells requires a non-invasive 
detection technique that is not subject to diffraction-limited spatial resolution. Fluorescence 
resonance energy transfer (FRET) is ideally suited for measuring nanoscale membrane 
organization (3). FRET studies of receptor microclustering have primarily used the direct 
attachment of donor and acceptor fluorescent proteins to the extracellular or intracellular 
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domain of the membrane protein (4, 5). Direct fluorophore attachment could potentially alter 
the receptor’s clustering properties, as well as their interaction with other biomolecules. This 
experimental approach also requires time-consuming protein cloning steps to attach the 
donor and acceptor fluorescent proteins to each protein mutant. 
 A recently reported FRET assay overcomes these problems (6). Shown in Fig. 1 is a 
schematic of this FRET assay, which is used to measure the microclustering of αPS2CβPS 
integrins. Integrins are heterodimeric cell membrane receptors that are pivotal to many 
cellular functions, and mediate signaling through both the cytoplasm and the extracellular 
matrix (1, 7). The integrin microclustering assay used FRET reporter peptides that were 
expressed in cells along with integrins. The FRET reporter peptides contain the integrins’ β 
subunit cytoplasmic and transmembrane domain fused to donor or acceptor fluorescent 
proteins. A previous report showed that the β cytoplasmic and transmembrane region is 
sufficient for clustering with full-length integrin in vivo (8). The donors and acceptors were a 
monomeric yellow fluorescent protein variant mVenus and a monomeric dsRED variant 
mCherry, respectively. Hereafter, the term FRET reporters refers to a population of donor 
transmembrane peptides and a separate population of acceptor transmembrane peptides.  
 The fusion of fluorescent proteins to the β subunit transmembrane and cytoplasmic 
domain to generate FRET reporters allows the donor and acceptor fluorophores to take part 
in integrin clustering. When integrins cluster, so do the FRET reporters. This results in a 
reduced average donor–acceptor separation distance and an increase in observed FRET. The 
use of FRET reporters eliminates the need to attach the donor and acceptor directly to the 
integrin, and does not require numerous steps to clone donor and acceptor fluorescent groups 
to each integrin mutant. The integrin diffusion and clustering properties are not altered in this 
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assay format since the fluorescent proteins are not directly attached to the integrins. The 
reporters: (a) do not contain ligand-binding domains so there is no competition between the 
integrin and FRET reporters for ligand; (b) do not alter the integrins’ ligand binding affinity; 
and (c) do not produce energy transfer in the absence of integrins (6). A set of FRET control 
peptides contained the same fluorescent proteins cloned to the transmembrane and 
cytoplasmic domains of a protein (mouse CD2) with no sequence homology in S2 cells. The 
assay has been used to measure receptor clustering, but it has not been demonstrated that it 
can be used to relate intracellular binding events with receptor clustering. This would enable 
a more detailed molecular understanding of cell membrane organization. 
 Reported herein is a systematic approach for identifying cytoplasmic proteins that 
affect receptor microclustering. The method uses the FRET assay described above along with 
RNA interference (RNAi) to reduce the expression of select proteins. Changes in energy 
transfer are measured to identify proteins that affect integrin microclustering. The 
cytoplasmic proteins that have been studied include: rhea (9), vinculin (10), paxillin (10), 
focal adhesion kinase (10), steamer duck (11), dreadlock (11), integrin-linked kinase (11)and 
actin42A (12). 
 
EXPERIMENTAL 
S2 cell culture 
 Transformed Drosophila S2 cells were cultured in Shields and Sang M3 insect media 
(M3, Sigma) supplemented with 10% fetal bovine serum (Irvine Scientific), 12.5 mM 
streptomycin, 36.5 mM penicillin, and 0.2 µM methotrexate (Fisher Scientific) in a 22°C 
incubator. Cells were co-transfected to express integrin subunits and FRET reporters or 
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FRET controls. Complete protein sequences for the FRET controls, FRET reporters 
containing mVenus or mCherry fluorescent proteins (6), wild-type and mutant integrin 
subunits (6, 13-15)have been published elsewhere. All endogenous proteins contain the heat 
shock promoter. 
 
dsRNA synthesis 
 Double-stranded RNA (dsRNA) was generated using published protocols with minor 
modifications, as noted below (16). Polymerase chain reactions were used to amplify 200 to 
700-bp DNA sequences from S2 genomic DNA. The primer sequences can be identified 
from the information listed in Table 1. Both forward and reverse primers contained the T7 
RNA polymerase promoter binding site (TAATACGACTCACTATAGGG). The polymerase 
chain reaction products were analyzed using 1% agarose gel electrophoresis and were 
subsequently used as templates for RNA synthesis with the MEGASCRIPT T7 Transcription 
Kit (Ambion, Austin, TX) to produce single stranded RNA. The single-stranded RNA 
products were ethanol-precipitated and re-suspended in water. dsRNAs was generated by 
incubating the solution at 65°C for 30 min followed by slow cooling to room temperature, 
and analyzed by 1% agarose gel electrophoresis to ensure that only the desired product was 
obtained. The concentration was measured using the solution absorbance at 280 nm and the 
solutions were diluted to 1 µg/µL. The dsRNA solution was stored at −20°C until subsequent 
use. 
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RNAi treatment 
 Detailed protocols have been previously published, and were followed with changes 
noted below (16, 17). Approximately 6×105 cells were plated per well in a 12-well cell 
culture dish. Cells were rinsed with 600 µL of serum-free M3 medium, and 300 µL of serum-
free media was added to each well. Ten micrograms of dsRNA was added directly to each 
well, and the cells were incubated for 60 min in a 22°C incubator followed by addition of 
300 µL M3 media containing 20 % fetal bovine serum. The cells were incubated at 22°C for 
an additional 4 days. Reduced expression of the target protein has been reported up to 5 days 
after RNAi treatment. 
 
FRET assay 
 After RNAi treatment and 4 days of incubation, cells were transferred from the cell 
culture dish to a polypropylene tube and heat-shocked for 30 min at 36°C to induce the 
expression of integrins and FRET reporters or controls. Cells were then placed in a 22°C 
incubator for 3 h to achieve maximum protein expression. The cells were centrifuged at 
approximately 600×g, the pellet was resuspended in serum-free medium and the 
concentration was adjusted to 3×105 cells/mL. The cells were placed on a RBB-tiggrin coated 
substrate and allowed to spread for 1 h in the serum-free medium. Details about the RBB-
tiggrin substrate are provided in the supplemental information. The medium was replaced 
with 20 mM BES Tyrodes buffer prior to analysis. The analysis was completed within 1.25 h 
of replacing the medium with BES buffer to ensure cell viability. At least three RNAi 
treatments were performed for every targeted protein and every cell line. The cells were 
analyzed using a ×60 magnification, numerical aperture 0.95 objective and a Eclipse 
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TE2000U microscope (Nikon) with low-intensity mercury lamp illumination. The images 
were captured with a Coolsnap CCD camera (Roper Scientific Photometrics, Pleasanton, 
CA) using the program Micromanager, which operates within the ImageJ 1.37v software. 
The camera was set to bin 8×8 pixels. Images were captured utilizing three different filter 
sets for each cell analyzed: (a) donor filter set (excitation 500/20 nm, emission 535/30 nm), 
(b) acceptor filter set (excitation 545/30 nm, emission 620/60 nm), and (c) donor excitation 
filter with acceptor emission filter (FRET filters). The exposure time for the FRET, acceptor 
and donor images were 12, 6, and 6 s, respectively. The Drosophila S2 cells did not move in 
the time it took to capture the three images.  
 
Data and statistical analysis 
 Data was analyzed using the program ImageJ, and a plugin that was developed with 
the Java platform. The plug-in calculates a FRET value for each pixel in the image. After the 
appropriate background value is subtracted from each pixel, a FRET value is calculated using 
the equation:  
     (1) 
where IDA, IAA, and IDD are intensities obtained from the images with the FRET, acceptor, 
and donor filters, respectively. The factors a, b, c, and d account for bleedthrough of: 
acceptor into the FRET filters, acceptor into the donor filters, donor into the acceptor filters, 
and donor into the FRET filters, respectively. All four bleedthrough factors were non-zero on 
the microscope system used in these studies. Further discussion of the bleedthrough factors 
AADD
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can be found in the supplemental information. There are numerous alternative FRET 
equations that can be used in conjunction with this methodology (18-20). Equation 1 is 
suitable for measuring increases or decreases in FRET efficiency after RNAi treatment.  
 All statistical analyses were performed using the application JMP 7 (SAS Institute 
Inc, Cary, USA), with statistical consulting through the Iowa State University Department of 
Statistics. For every reported value, at least 100 cells from three replicate experiments were 
analyzed. The raw FRET data are not normally distributed, which means that statistical tests 
such as the t-test cannot be used on the raw data. The data were transformed to a normal 
distribution by taking the natural log of the raw data, and the means were calculated from the 
transformed data. The Welch test was used to compare the means of the log-transformed data 
since the data sets were determined to have unequal variances by Levene’s test. Results of 
the Welch Test are reported as p values, which are a measure of the significance of the 
statistical tests. A p value lower than 0.05 provides evidence that the energy transfer 
measured for the RNAi treatment data set is altered compared to the no RNAi treatment data 
set. A p value greater than 0.05 does not provide the statistical evidence to say there is a 
difference between the data sets. In order to report the mean value in the original data scale, 
the antilog of the mean of the log-transformed data was taken. Further information on these 
methods can be found in statistics textbooks (21). 
 
RESULTS AND DISCUSSION 
FRET assay 
 Figure 1 shows a schematic of the FRET assay used to study the effect of cytoplasmic 
proteins on integrin microclustering in live cells. A set of three images is captured for each 
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cell: donor, acceptor, and FRET. Figure 2 shows a series of images used to calculate energy 
transfer in cells expressing wild-type integrins and FRET reporters. Using a home-built plug-
in for the program ImageJ, an energy transfer value is calculated for each pixel in the image 
using Eq. 1. A region of interest (ROI) is generated for each cell. Specifically, background 
regions and regions corresponding to the nuclear and perinuclear regions are excluded from 
the analysis. Intense fluorescence is observed in these regions, corresponding to FRET 
reporters inside the cell. The signal from the nuclear and perinuclear regions interferes with 
the measurement of integrin clustering in the cell membrane. An example ROI is shown in 
Fig. 2. An average value is calculated from all the pixels in a ROI to generate a single FRET 
value for each cell. The distribution of FRET values for all pixels in the example ROI is 
provided in the supplemental information (Supplemental Figure S1).In order to ensure that a 
suitable ROI can be defined, only spread cells with diameters greater than 20 µm are 
analyzed. The average diameter of the spread cells analyzed by FRET did not statistically 
differ for any of the cell lines or RNAi treatments (data not shown). 
 In order to measure intracellular events that affect integrin clustering, without 
interference from extracellular ligand binding, minimizing extracellular signaling is 
desirable. To accomplish this, cells were spread on a surface with low ligand density. The 
extracellular ligand for the integrins used in these studies (RBB-tiggrin) is a 53 amino acid 
protein. Assuming RBB-tiggrin’s size is 2 nm×3 nm (22), and all the RBB-tiggrin adheres to 
the glass slide, approximately 3% to 5% of the 30 mm2 glass slide is covered at the ligand 
density used in these studies. Bovine serum albumin is used to cover the remaining glass 
surface to inhibit non-specific cell binding to the glass. A surface with no ligand, coated only 
with bovine serum albumin, would completely eliminate extracellular signaling events. 
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However, cell attachment and cell spreading were significantly reduced when no ligand was 
present. The reduced cell spreading in the absence of ligand precluded FRET measurements 
on a large-enough number of cells to provide statistically significant results.  
 Energy transfer was measured in cells expressing integrins and FRET reporter 
peptides or FRET control peptides. The integrins were either wild-type or mutants. Two 
well-characterized integrin mutants that are studied have different ligand-binding affinities 
compared to wild-type integrin. The mutant αanaβ integrins contain a two-point mutation in 
the cytoplasmic domain of the α subunit. This mutation is considered to mimic signal 
transduction from inside to outside the cell (23). The mutant αβV409D integrins contain a 
single-point mutation in the extracellular domain of the β subunit that mimics signal 
transduction from outside to inside the cell (24). 
 At 3% to 5% ligand surface densities, statistically similar energy transfer values were 
measured for three cell lines expressing wild-type or mutant (αanaβ, αβV409D) integrins and 
FRET reporters (Table 2). This indicates similar levels of FRET reporter microclustering for 
the three cell lines at these experimental conditions. Similar energy transfer values are also 
obtained for cells expressing wild type integrins and FRET reporters compared to cells 
expressing wild-type integrins and FRET controls (Table 2). Three factors must be 
considered to interpret these results: (1) the energy transfer values are above the detection 
limit for the microscope system; (2) the total energy transfer measured is a result of integrin-
specific FRET reporter clustering and non-integrin-specific FRET reporter clustering from 
many sources; (3) at high ligand densities, higher energy transfer values are measured for 
cells expressing FRET reporters compared to cells expressing FRET controls. At 3% to 5% 
ligand densities, the energy transfer reported in Table 2 (αβ FRET Reporters, αanaβ FRET 
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Reporters, αβV409D FRET Reporters) is the result of non-integrin-specific microclustering 
of the FRET reporters. Integrin-specific clustering would be detected as an increase in energy 
transfer for the cell line expressing FRET reporters relative to the cell line expressing FRET 
controls, which is observed at high ligand densities (6). It is not possible to say that no 
integrin microclustering occurs at 3% to 5% ligand density. Integrin microclustering that 
causes an insignificant increase in FRET reporter microclustering relative to the non-
integrin-specific microclustering of the FRET reporter may be present. The data presented in 
Table 2 is referred to as the no RNAi treatment data in the following discussion. 
 
RNAi transfection 
 RNAi was used to reduce the expression of select cytoplasmic proteins. The proteins 
targeted in this work are highlighted gray in Fig. 1. These proteins are known to be involved 
in integrin-signaling complexes, and are expressed in S2 cells as reported in the FLIGHT 
mRNA microarray expression database (24) and PeptideAtlas mass spectrometry proteomics 
database (25). S2 cells are a Drosophila cell culture system. Due to substantial structural 
homology between vertebrate and invertebrate integrins, as well as a similarity between 
many of the integrin-signaling pathways, information learned about integrin microclustering 
in Drosophila cells can be used to advance the understanding of vertebrate integrins (26). 
 The choice of Drosophila cell culture is optimal for these studies because rapid, 
simple, and selective reduction in protein expression is possible using RNAi (16, 27). A 
similar technique used in mammalian cell culture, short-interfering RNA (i.e., siRNA), often 
suffers from low specificity for the targeted protein and an immune response to the RNA. In 
RNAi experiments, approximately 500-bp double-stranded RNA corresponding to the 
118 
 
mRNA sequence of the targeted protein is used to reduce protein expression. Whole-genome 
RNAi studies have been performed, and the sequences used to reduce protein expression in 
these studies are published and available in several online resources (28, 29). The RNAi 
probes used in this study were selected from these resources. Two criteria were used in 
selecting the RNAi probes: thermodynamic binding efficiency and selectivity. The selectivity 
is a measure of other proteins that may be targeted by the RNAi probe. Since the goal of this 
work is to identify specific proteins that affect integrin microclustering, only probes with 
100% selectivity to the targeted protein were chosen for the FRET studies (other targets, 
Table 1). The actin42A probe targets the entire class of actin proteins, but does not target 
other protein classes. Once internalized, the approximately 500- bp dsRNA is reduced to 
approximately 21-bp fragments.The thermodynamic binding efficiency presented in Table 1 
is a measure of how many of the possible 21-mers have thermodynamically favorable 
binding to the target mRNA. This value is not necessarily reflective of the amount the 
target protein’s expression is reduced. For a given protein, RNAi probes with 100% 
selectivity and the highest efficiency were selected. Another important consideration is 
possible changes in cell viability after RNAi treatment. None of the RNAi treatments altered 
cell viability compared to cells that did not receive RNAi treatment (data not shown).  
 A cell line expressing green fluorescent protein (GFP) fused to actin 42A was used 
show that the RNAi protocol used in these studies facilitates the delivery of dsRNA into the 
cytoplasm. Four days after RNAi treatment against actin 42A, a 21% reduction in the GFP 
fluorescence was measured compared to cells that did not receive RNAi treatment 
(Supplemental Figure S2). The reduction in protein expression will vary with each RNAi 
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probe. Typical RNAi knockdown efficiencies for Drosophila cell culture are between 95–
99% and 62–100% using Western blotting and cell phenotype analysis, respectively (16, 30).  
 
Cytoplasmic proteins that affect integrin microclustering 
 Figure 3 (black data bars) shows the average FRET values for at least 100 S2 cells 
expressing wild-type integrins and FRET reporters after the indicated RNAi treatment. The 
data were normalized and statistically compared to the value obtained for the no RNAi 
treatment data.  
 Four of the RNAi treatments resulted in higher levels of energy transfer compared to 
the no RNAi treatment data: vinculin, paxillin, rhea, and focal adhesion kinase. The higher 
energy transfer values indicate an increase in the microclustering of the FRET reporters, 
which may be due to integrin-specific interactions, non-integrin-specific interactions or a 
combination of both, as discussed above. This can be determined by measuring the energy 
transfer in a cell line expressing integrins and FRET control peptides (Fig. 3, gray data bars). 
If the increase in energy transfer measured after RNAi treatment for cells expressing 
integrins and FRET reporters is non-integrin-specific, then increased energy transfer is 
expected in the cell line expressing the FRET controls. However, if the increase in energy 
transfer is the result of integrin-specific interactions, no change in energy transfer is expected 
for the cell line expressing the FRET controls. There was no statistically significant change 
in energy transfer after any of the RNAi treatments for cells expressing the FRET controls. 
These results indicate that the increase in energy transfer measured in the cell line containing 
the FRET reporters, after vinculin, paxillin, rhea, and focal adhesion kinase RNAi treatment, 
is measuring integrin-dependent increases in FRET reporter microclustering. Reducing the 
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expression of these cytoplasmic proteins increases FRET reporter clustering due to increased 
integrin microclustering. These proteins prevent integrin microclustering under the 
conditions used in these studies.  
 It is not possible to relate the magnitude change in energy transfer to a magnitude 
change in integrin microclustering using Eq. 1. Furthermore, the change in integrin 
microclustering may be dependent on how much protein expression is reduced. For each 
RNAi-targeted protein, the amount its expression is reduced may differ. Different 
thermodynamic efficiencies (Table 1), the amount of target mRNA within the cell, and 
differential transport of the dsRNA probe across the cell membrane will influence how 
efficient the overall RNAi treatment is in reducing expression. The methodology reported 
here can be used to determine the cytoplasmic proteins that alter integrin microclustering, 
which has important implications for intracellular signaling events. On-going efforts will 
enable a quantitative connection between the change in energy transfer and the change in 
integrin microclustering.  
 
Cytoplasmic proteins that affect the microclustering of integrin mutants  
 Details about the molecular mechanism of protein clustering can be obtained by 
studying protein mutants. Figure 4 (black data bars) shows the FRET values for S2 cells 
expressing αβV409D mutant integrins and FRET reporters after the indicated RNAi 
treatment. In addition to the four cytoplasmic proteins identified as increasing energy transfer 
in cells expressing wild-type integrins, an additional RNAi treatment show a statistically 
significant increase in energy transfer compared to wild-type cells. This protein is dreadlock, 
which forms a link between integrins and receptor tyrosine kinases. This suggests that 
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disruption of the cytoplasmic linkage between αβV409D integrins and receptor tyrosine 
kinases results in higher integrin microclustering.  
 A previous study revealed the microclustering of the αβV409D integrin mutant is 
dependent on the presence of other membrane proteins (6). When the extracellular domains 
of all membrane proteins were digested from the cell surface prior to expressing the integrins 
and FRET reporters, the microclustering of the αβV409D mutant decreased. In contrast, there 
was no change in the microclustering of wild-type integrins when the extracellular domains 
of other membrane proteins were removed from the cell membrane. The previous study did 
not reveal the identity of the membrane protein(s) responsible for the microclustering of the 
αβV409D mutant since all membrane proteins were simultaneously targeted for removal. In 
addition, the transmembrane and cytoplasmic domains of the other membrane proteins 
remained in the membrane, and key integrin contacts in the cytoplasm may not have been 
disrupted. The use of FRET reporters and RNAi, as outlined in this report, has the benefit 
over previous methods for measuring the molecular mechanism of receptor clustering 
because the entire protein is removed,not just a fragment of the protein, and an individual 
protein can be targeted. The FRET results for the αβV409D mutant reveal receptor tyrosine 
kinase is at least one membrane protein responsible for its altered microclustering, via the 
cytoplasmic protein dreadlock, compared to wild-type integrins. 
 In comparison to the  αβV409D mutation, the αanaβ mutation’s microclustering 
properties were altered only with RNAi treatment for paxillin at 3% to 5% ligand density 
(Fig. 4, gray data bars). When the same RNAi probe is used to reduce the expression of a 
cytoplasmic protein in different populations of the same cell type (e.g. S2 cells), the 
magnitude of the change in energy transfer can be cautiously compared. The FRET data 
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indicates a 1.6-fold increase in FRET after paxillin RNAi treatment as opposed to six- and 
four-fold increase with wild-type and αβV409D mutant integrins, respectively. The 
remaining RNAi treatments that were studied showed no statistically significant differences 
for the αanaβ mutation compared to the no RNAi treatment data. The lack of change in 
integrin microclustering for the αanaβ mutation reflects a ‘defect’ in the ability of the 
cytoplasmic proteins to participate in the microclustering of this mutation. The lack of 
change in energy transfer for the αanaβ mutation is not the result of higher microclustering 
levels prior to the RNAi treatments.The energy transfer value obtained for the αanaβ no 
RNAi treatment data is similar to the values for cells expressing wild-type and the αβV409D 
mutation (Table 2). Therefore, αanaβ integrin microclustering levels are similar to other cell 
lines at 3% to 5% ligand density, prior to RNAi treatment. Additionally, higher energy 
transfer values have been measured for this cell line in the presence of a high ligand 
concentration (6), indicating that increased microclustering is possible under some 
circumstances.  
 It should not be surprising that decreased energy transfer was not measured after any 
of the RNAi treatments. As discussed above, at 3% to 5% ligand density the energy transfer 
measured before treatment is from non-integrin-specific microclustering of the FRET 
reporters, and the integrin-specific microclustering that may be present is below the detection 
limit for this assay. The cytoplasmic proteins that prevent integrin microclustering, in the 
absence of binding to extracellular ligand, have been identified. When the expression of these 
proteins is reduced, increased energy transfer is measured. When the ligand density is 50% 
on the glass surface, integrin microclustering levels are higher than what is measured at 3% 
to 5% ligand densities. Preliminary studies utilizing cells spread on a densely coated ligand 
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surface have revealed that decreased energy transfer values after RNAi treatment can be 
obtained (unpublished data).  
 
CONCLUSION 
 The organization of the cell membrane is important for many basic cell functions, and 
can lead to pathological conditions when it is altered. Currently, few non-invasive analytical 
techniques can measure intracellular events that lead to changes in the organization of the 
cell membrane. The combination of FRET and RNAi has the unique capacity for measuring 
integrin organization without altering the integrin dynamics. Specific cytoplasmic events 
leading to integrin microclustering can be identified. When cells are spread on a surface with 
3% to 5% ligand density, it was found that four proteins that connect integrins to the 
cytoskeleton also affect integrin microclustering. The molecular mechanism of integrin 
microclustering is further understood by analyzing integrin mutants. The microclustering of a 
mutation (αβV409D) that affects the ligand-binding domain is more sensitive to cytoplasmic 
interactions that indirectly link integrins to receptor tyrosine kinases compared to wild-type 
integrins. On 3% to 5% ligand surface densities, an alpha cytoplasmic mutation (αanaβ) loses 
its sensitivity to microclustering when the expression of all cytoplasmic proteins studied, 
except paxillin, is reduced. This methodology is not limited to integrins. Similar strategies 
can be used to study other classes of cell membrane receptors, and will enable a complete 
understanding of how receptor organization is directed by cytoplasmic binding events.  
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Table 1 RNAi probes used to reduce protein expression in S2 cells 
 
Cytoplasmic Protein RNAi probe ID 
Thermodynamic 
binding 
efficiencya 
Other protein 
targets 
Vinculin (Vin) HFA18728 33/493 No 
Paxillin (Pax) BKN29242 72/293 No 
Rhea HFA11300 101/487 No 
Focal Adhesion Kinase 
(FAK) HFA07426 136/483 No 
Integrin Linked Kinase 
(ILK) HFA11868 89/469 No 
Dreadlock (Dock) HFA00812 44/220 No 
Steamer Duck (SD) HFA17070 19/249 No 
Actin42A HFA04835 53/480 Yes 
 
 
The RNAi probe ID, efficiency and other target values are from published and online 
resources: http://flyrnai.org 
 
 
a The first value in the column is the number of 21 base pair oligonucleotides that have 
thermodynamically favorable binding to the target mRNA,and the second value in the 
column is the total number of 21 base pair oligonucleotides generated from the RNAi probe 
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Table 2 Mean FRET values from at least 100 cells expressing FRET reporters or controls and 
the indicated integrins: αβ, wild-type; αanaβ, α cytoplasmic mutation; αβV409D, β 
extracellular domain mutation 
 
αβ 
FRET Reporters 
αanaβ 
FRET Reporters 
αβV409D 
FRET Reporters 
αβ 
FRET Controls 
0.013 0.016  (p=0.33) 0.017  (p=0.23) 0.013 (p=0.96) 
 
 
Cells are spread on a glass surface coated with a 3% to 5% ligand density, all data are 
statistically compared to the value obtained for cells expressing wild-type integrins with 
FRET reporters 
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Fig. 1 Schematic showing FRET assay and proteins known to be involved in integrin-
signaling complexes. Cytoplasmic proteins targeted in this study to measure how they affect 
integrin micro-clustering: rhea, vinculin, actin, integrin-linked kinase (ILK); CG32528, 
paxillin, dreadlock (Dock); steamer duck and focal adhesion kinase (FAK). (top) No energy 
transfer takes place when FRET reporters are separated by greater than 10 nm. (bottom) 
Reduced expression of a target cytoplasmic protein (e.g., Paxillin) increases integrin 
clustering and increases energy transfer from donor (D) fluorescent protein to acceptor (A) 
fluorescent protein. This is a static picture of a dynamic system. 
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Fig. 2 Fluorescence images of a transformed Drosophila S2 cell, expressing αPS2CβPS 
integrins and FRET reporters. Image obtained using (top) donor filter set; (middle) acceptor 
filter set; (bottom) FRET filter set. Color has been added to correspond to the emission filter 
used to generate each image. FRET values are calculated on a pixel-by-pixel basis according 
to Eq. 1. A region of interest is generated for each cell that excludes fluorescence emanating 
from inside the cell. An example region of interest is shown in the top image (green)  
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Fig. 3 Normalized FRET values for S2 cells expressing wild-type integrins and FRET 
reporters (black data bars) or wild-type integrins and FRET controls (gray data bars) after the 
indicated RNAi treatment. All values are normalized to the no RNAi treatment data (Table 
2). A p value below 0.05, shows statistical evidence that the energy transfer measured after 
RNAi treatment is altered compared to the no RNAi treatment data set. The abbreviations 
used in this figure are listed in Table 1 
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Fig. 4 Normalized FRET values for S2 cells expressing αβV409D mutant integrins and 
FRET reporters (black data bars) or αanaβ mutant integrins and FRET reporters (gray data 
bars) after the indicated RNAi treatment. A p value below 0.05 shows statistical evidence 
that the energy transfer measured after RNAi treatment is altered compare to the no RNAi 
treatment data set. The abbreviations used in this figure are listed in Table 1  
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Supplemental Experimental Methods 
 
FRET Bleed-through Factors 
 The factors a, b, c, and d account for bleed-through of: acceptor into the FRET filters, 
acceptor into the donor filters, donor into the acceptor filters, and donor into the FRET filters, 
respectively. These values were measured in cell lines that contained only the acceptor FRET 
control plus wild-type integrins (for a and b) or donor FRET control plus wild-type integrins 
(for c and d). The data (not shown) for these bleed-through factors reveal a dependence on 
the amount of donor and acceptor expressed in the cell, and were fit to exponential curves:  
 
   a = 0.103 + 0.565·exp(-0.540×10-2·IAA);    (2) 
   b = 0.013 + 0.274·exp(-0.466×10-2·IAA);    (3) 
   c = 0.077 + 0.344·exp(-0.905×10-2·IDD);    (4) 
   d = 0.276 - 0.027·exp(-0.346×10-3·IDD).    (5) 
 
 For the FRET calculations, if the donor fluorescence intensity was below 50 or the 
acceptor fluorescence intensity was below 50, the cell was rejected from the analysis.  These 
lower threshold values were used to minimize the residual between the exponential fit and 
experimental bleed-through factor experimental data. The applied bleed-through factor was 
determined on a pixel-by-pixel basis during the FRET calculation. Background subtraction 
was performed on all images using an average intensity from cell-free regions of the image, 
and zero cellular autofluorescence was observed in the donor, acceptor or FRET images 
using the stated acquisition parameters. 
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Preparation of RBB-Tiggrin Surfaces 
RBB-tiggrin is a bacterial fusion protein containing the integrin binding domain of the 
extracellular matrix protein tiggrin. RBB-tiggrin was produced as described previously.17 
Glass microscope slides (Fisherbrand, Fisher Scientific) were sterilized in 70% ethanol for 15 
min and dried in a sterile environment. They were coated with a sterile solution containing 
0.05 µg/mL RBB-tiggrin in pH 7 phosphate-buffered saline (PBS) for 2 h. The RBB- tiggrin 
solution was then removed and any remaining exposed glass surface was blocked using a 10 
mg/mL solution of bovine serum albumin in pH 7 PBS. Coated slides were stored overnight 
at 2 °C and used within 24 h. 
 
Actin-GFP Assay 
S2 cells expressing integrins, UASpGFP tagged actin42A and pAdhGAL4, were RNAi 
treated for actin42A. Using these constructs, expression of actin42A-GFP is constitutively 
active. After RNAi treatment and incubation for 4 days, cells were transferred from the cell 
culture dish and collected by centrifugation. Cells were prepared for microscopy as described 
above for the FRET assay. The cells were imaged using a GFP filter set (excitation 470/50 
nm and emission 545/75 nm). 
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Figure S1: Distribution of FRET values for one cell. The X-axis represents FRET value and 
the Y-axis denotes the number of pixels with a given FRET value. All values reported in this 
image are multiplied by a factor of 100, relative to the FRET values reported in Table 2 of 
the main text. 
 
 
 Figure S2: RNA knock-down efficiency.
treatments in reducing protein expression, a cell line expressing cytoskeletal protein actin42A 
tagged with green fluorescent protein (GFP) was utilized. The cells were treated with dsRNA 
for actin42A. This dsRNA also targeted five other actins expressed in S2 cells. Fluorescence 
intensities were measured after incubating 4 days with dsRNA. Shown in Figure S2A (left) is 
the fluorescence image of control cells expressing actin42A
image of the same cell line after actin42A RNAi treatment. Both images are shown in the 
same intensity scale. The histograms in Figure S2B show the fluorescence of 100 cells (left) 
for control cells expressing actin42A
average. The mean fluorescence value for the control cell line is 590 and after RNAi 
treatment the mean value is 466. A statistically significant reduction in fluorescence is 
measured after RNAi treatment, as determined using the Welch Test (p
 
 
 
 
 
 
 
 
 
 
 
 
 
 In order to estimate the efficacy of the RNAi 
-GFP and (right) the fluorescence 
-GFP and (right) the same cell line af
=0.008). 
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